About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
2195 genotypes with 4019 annotations displayed of selected term and subterms
Searched Term: adipose tissue phenotype
Allelic Composition
(Genetic Background)
Annotated Term Reference
1700086L19Riktm1b(EUCOMM)Wtsi/1700086L19Riktm1b(EUCOMM)Wtsi
(C57BL/6N-1700086L19Riktm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
1810026B05Rikem1Wei/1810026B05Rik+
(involves: BALB/c * C57BL/6)
decreased total fat pad weight J:281371
1810026B05Rikem2Wei/1810026B05Rik+
(involves: BALB/c * C57BL/6)
decreased total fat pad weight J:281371
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp)
increased total body fat amount J:211773
2300002M23Riktm1Lex/2300002M23Riktm1Lex
(B6;129S5-2300002M23Riktm1Lex/Mmucd)
decreased total body fat amount J:171883
3830406C13Riktm1b(KOMP)Wtsi/3830406C13Riktm1b(KOMP)Wtsi
(C57BL/6N-3830406C13Riktm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
increased total body fat amount J:211773
4930404H24Riktm1a(KOMP)Wtsi/4930404H24Riktm1a(KOMP)Wtsi
(C57BL/6N-4930404H24Riktm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
increased total body fat amount J:211773
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
decreased gonadal fat pad weight J:168271
Ay/a
(involves: KK)
increased total body fat amount J:26460
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
adipose tissue phenotype J:168271
Ay/A
(involves: C57BL/6)
increased brown adipose tissue amount J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased percent body fat/body weight J:131039
increased retroperitoneal fat pad weight J:131039
Ay/A
Prkar2btm2Gsm/Prkar2b+

(involves: C57BL/6)
increased percent body fat/body weight J:131039
Ay/A
Prkar2btm2Gsm/Prkar2btm2Gsm

(involves: C57BL/6)
increased brown adipose tissue amount J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased percent body fat/body weight J:131039
increased retroperitoneal fat pad weight J:131039
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6)
decreased white adipose tissue amount J:96865
Abca14tm1.1(NCOM)Mfgc/Abca14tm1.1(NCOM)Mfgc
(C57BL/6N-Abca14tm1.1(NCOM)Mfgc/Tcp)
decreased total body fat amount J:211773
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6)
abnormal brown adipose tissue morphology J:122438
abnormal fat cell morphology J:122438
Abcg2tm1.1(KOMP)Vlcg/Abcg2+
(B6N(Cg)-Abcg2tm1.1(KOMP)Vlcg/J)
increased total body fat amount J:211773
Abfp4DBA/2/Abfp4DU6i
Abfp5DU6i/Abfp5DU6i

(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:101006
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
abnormal adipose tissue morphology J:234876
browned white adipose tissue morphology J:234876
decreased body fat mass J:234876
decreased brown fat cell size J:234876
decreased white fat cell size J:234876
increased adipocyte glucose uptake J:234876
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(C57BL/6N-Abhd16atm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Abhd17atm1a(KOMP)Wtsi/Abhd17atm1a(KOMP)Wtsi
(C57BL/6N-Abhd17atm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
decreased subcutaneous adipose tissue amount J:68427
decreased total body fat amount J:68427
Acad8m1Ytc/Acad8m1Ytc
(involves: C57BL/6)
decreased brown fat cell lipid droplet size J:222356
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6)
abnormal adipose tissue morphology J:102010
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
abnormal adipose tissue physiology J:106714
abnormal brown adipose tissue morphology J:106714
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal epididymal fat pad morphology J:128859
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal epididymal fat pad morphology J:128859
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi)
decreased brown adipose tissue mass J:235775
decreased brown fat cell lipid droplet size J:235775
decreased epididymal fat pad weight J:235775
decreased inguinal fat pad weight J:235775
increased epididymal fat pad weight J:235775
Achetm1.1Hssh/Achetm1.1Hssh
(involves: 129S4/SvJae * C57BL/6)
adipose tissue phenotype J:140622
decreased white adipose tissue amount J:140622
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0

(involves: C57BL/6 * SJL)
increased gonadal fat pad weight J:203753
increased inguinal fat pad weight J:203753
increased total body fat amount J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
abnormal brown adipose tissue morphology J:182660
abnormal brown adipose tissue physiology J:182660
abnormal brown adipose tissue thermogenesis J:182660
abnormal brown fat cell morphology J:182660
decreased brown fat cell lipid droplet size J:182660
increased adipocyte glucose uptake J:182660
increased brown adipose tissue amount J:182660
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6)
decreased epididymal fat pad weight J:183258
decreased white adipose tissue amount J:183258
Acot13tm1Deco/Acot13tm1Deco
(Not Specified)
decreased brown fat cell lipid droplet size J:204997
Acsf2tm1.1(KOMP)Vlcg/Acsf2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsf2tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Acsl1tm1Rcol/Acsl1tm1Rcol
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * C57BL/6 * DBA)
adipose tissue phenotype J:155714
Acsl1tm1Rcol/Acsl1tm1Rcol
Tg(Fabp4-cre)1Rev/0

(involves: 129P2/OlaHsd * C57BL/6)
increased body fat mass J:162996
increased epididymal fat pad weight J:162996
increased gonadal fat pad weight J:162996
Acsm2tm1.1(KOMP)Vlcg/Acsm2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsm2tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
decreased brown adipose tissue amount J:78070
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J)
decreased epididymal fat pad weight J:160212
Ad/Ad
(involves: Chr 7 marker stock * Wild stock)
increased abdominal adipose tissue amount J:6095
increased fat cell size J:6095
increased total body fat amount J:6095
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock)
abnormal abdominal fat pad morphology J:6095
increased fat cell size J:6095
increased total body fat amount J:6095
increased white adipose tissue amount J:6095
Adam12tm1Asf/Adam12tm1Asf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased brown adipose tissue amount J:81009
Adam32tm1b(KOMP)Wtsi/Adam32tm1b(KOMP)Wtsi
(B6N(Cg)-Adam32tm1b(KOMP)Wtsi/2J)
increased total body fat amount J:211773
Adamts1tm1Hku/Adamts1tm1Hku
(involves: 129S6/SvEvTac * C57BL/6)
decreased total body fat amount J:62260
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg)
abnormal adipose tissue amount J:280282
Adcy1tm1b(EUCOMM)Wtsi/Adcy1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy1tm1b(EUCOMM)Wtsi/H)
decreased total body fat amount J:211773
Adcy3Jll/Adcy3+
(C57BL/6J-Adcy3Jll)
decreased brown fat cell size J:223554
decreased percent body fat/body weight J:223554
decreased total body fat amount J:223554
decreased white fat cell size J:223554
Adcy3Jll/Adcy3+
(involves: 129S1/SvImJ * C57BL/6J)
decreased percent body fat/body weight J:223554
decreased total body fat amount J:223554
Adcy3Jll/Adcy3Jll
(involves: 129S1/SvImJ * C57BL/6J)
decreased total body fat amount J:223554
Adcy3tm1a(EUCOMM)Wtsi/Adcy3+
(C57BL/6N-Adcy3tm1a(EUCOMM)Wtsi/Wtsi)
increased total body fat amount J:211773
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
decreased white adipose tissue amount J:71968
Adgra1tm1b(EUCOMM)Hmgu/Adgra1tm1b(EUCOMM)Hmgu
(B6N(Cg)-Adgra1tm1b(EUCOMM)Hmgu/J)
decreased total body fat amount J:211773
Adip1LG/J/?
Capn10tm1Chev/Capn10+

((B6.129-Capn10tm1Chev x LG/J)F1)
increased gonadal fat pad weight J:153477
increased inguinal fat pad weight J:153477
increased mesenteric fat pad weight J:153477
increased renal fat pad weight J:153477
increased total fat pad weight J:153477
Adip1LG/J/Adip1LG/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip2LG/J/Adip2LG/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip3LG/J/Adip3LG/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip3LG/J/Adip3SM/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip4LG/J/Adip4LG/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip5LG/J/Adip5LG/J
(involves: LG/J * SM/J)
decreased white adipose tissue amount J:62610
Adip5LG/J/Adip5SM/J
(involves: LG/J * SM/J)
decreased white adipose tissue amount J:62610
Adip6LG/J/Adip6LG/J
(involves: LG/J * SM/J)
decreased total body fat amount J:62610
Adip7LG/J/?
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip8LG/J/Adip8LG/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip8LG/J/Adip8SM/J
(involves: LG/J * SM/J)
increased white adipose tissue amount J:62610
Adip9129P3/J/Adip9C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ)
increased white adipose tissue amount J:83139
Adip9C57BL/6ByJ/Adip9C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ)
increased white adipose tissue amount J:83139
Adip10NZB/BlNJ/Adip10SM/J
(involves: NZB/BlNJ * SM/J)
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip10SM/J/Adip10SM/J
(involves: NZB/BlNJ * SM/J)
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip11NZB/BlNJ/Adip11SM/J
(involves: NZB/BlNJ * SM/J)
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip11SM/J/Adip11SM/J
(involves: NZB/BlNJ * SM/J)
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip12NZB/BlNJ/Adip12SM/J
(involves: NZB/BlNJ * SM/J)
increased mesenteric fat pad weight J:103841
Adip12SM/J/Adip12SM/J
(involves: NZB/BlNJ * SM/J)
increased mesenteric fat pad weight J:103841
Adip13NZB/BlNJ/Adip13NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
Adip13NZB/BlNJ/Adip13SM/J
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
Adip14NZB/BlNJ/Adip14SM/J
(involves: NZB/BlNJ * SM/J)
increased retroperitoneal fat pad weight J:103841
Adip15NZB/BlNJ/Adip15SM/J
(involves: NZB/BlNJ * SM/J)
increased mesenteric fat pad weight J:103841
Adip16NZB/BlNJ/Adip16SM/J
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip16SM/J/Adip16SM/J
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip17NZB/BlNJ/Adip17SM/J
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip17SM/J/Adip17SM/J
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
increased retroperitoneal fat pad weight J:103841
Adip18NZB/BlNJ/Adip18NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip18NZB/BlNJ/Adip18SM/J
(involves: NZB/BlNJ * SM/J)
increased gonadal fat pad weight J:103841
increased inguinal fat pad weight J:103841
Adip20129P3/J/Adip20129P3/J
(involves: 129P3/J * C57BL/6ByJ)
abnormal fat pad morphology J:116127
increased gonadal fat pad weight J:116127
increased retroperitoneal fat pad weight J:116127
increased white adipose tissue amount J:83139
Adip20129P3/J/Adip20129P3/J
Adip9C57BL/6ByJ/Adip9C57BL/6ByJ

(involves: 129P3/J * C57BL/6ByJ)
increased white adipose tissue amount J:83139
Adip20129P3/J/Adip20C57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ)
abnormal fat pad morphology J:116127
increased gonadal fat pad weight J:116127
increased retroperitoneal fat pad weight J:116127
increased white adipose tissue amount J:83139
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J)
increased percent body fat/body weight J:111346
increased total body fat amount J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far

(involves: 129S4/SvJae * C57BL/6J)
decreased percent body fat/body weight J:111346
decreased total body fat amount J:111346
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
abnormal abdominal fat pad morphology J:199264
abnormal white adipose tissue morphology J:199264
decreased total fat pad weight J:199264
Adipoqtm1Ish/Adipoqtm1Ish
Dbhtm1Rpa/Dbh+

(involves: 129S7/SvEvBrd * C57BL/6J)
adipose tissue phenotype J:199264
Adipoqtm1Ish/Adipoqtm1Ish
Lepob/Lepob

(involves: 129S7/SvEvBrd * C57BL/6J)
increased total fat pad weight J:199264
Adipoqtm1Pesch/Adipoqtm1Pesch
(B6.129S7-Adipoqtm1Pesch)
abnormal inguinal fat pad morphology J:210480
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc)
increased brown adipose tissue amount J:122027
increased percent body fat/body weight J:122027
increased white adipose tissue amount J:122027
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen)
abnormal abdominal fat pad morphology J:122027
abnormal brown fat cell morphology J:122027
decreased brown adipose tissue mass J:122027
decreased fat cell size J:122027
decreased gonadal fat pad weight J:122027
decreased percent body fat/body weight J:122027
decreased renal fat pad weight J:122027
Adora1tm1b(KOMP)Wtsi/Adora1tm1b(KOMP)Wtsi
(B6N(Cg)-Adora1tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Adpgktm2a(EUCOMM)Wtsi/Adpgktm2a(EUCOMM)Wtsi
(C57BL/6N-Adpgktm2a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
increased percent body fat/body weight J:87718
Adrb1tm1Bkk/Adrb1tm1Bkk
Adrb2tm1Bkk/Adrb2tm1Bkk
Adrb3tm1Lowl/Adrb3tm1Lowl

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)
abnormal brown adipose tissue morphology J:79309
increased brown fat cell size J:79309
increased interscapular fat pad weight J:79309
increased total body fat amount J:79309
Adrb2tm1Bkk/Adrb2tm1Bkk
(FVB.129-Adrb2tm1Bkk)
abnormal epididymal fat pad morphology J:55552
Adrb3tm1Jpg/Adrb3tm1Jpg
(involves: 129S4/SvJae * C57BL/6J)
increased percent body fat/body weight J:42702
increased total body fat amount J:42702
Adrb3tm1Lowl/Adrb3tm1Lowl
(FVB/N-Adrb3tm1Lowl)
increased parametrial fat pad weight J:30060
increased total body fat amount J:30060
Adrm1Gt(OST128063)Lex/Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
abnormal abdominal fat pad morphology J:166694
increased total body fat amount J:166694
Aebp1tm1Hsro/Aebp1+
(involves: 129S4/SvJae * C57BL/6J)
decreased total body fat amount J:125333
Aebp1tm1Hsro/Aebp1tm1Hsro
(involves: 129S4/SvJae * C57BL/6J)
abnormal fat cell morphology J:125333
abnormal white adipose tissue morphology J:125333
decreased total body fat amount J:125333
decreased white adipose tissue amount J:125333
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd)
decreased total body fat amount J:211773
Afg3l1tm1.1Arte/Afg3l1tm1.1Arte
Afg3l2tm1Arte/Afg3l2tm1Arte
Tg(Plp1-cre/ERT)3Pop/0

(involves: C57BL/6J * C57BL/6N)
decreased body fat mass J:237410
Afpq9DBA/2/Afpq9DU6i
(involves: DBA/2J * DU6i)
abnormal abdominal fat pad morphology J:66233
Afpq9DU6i/Afpq9DU6i
(involves: DBA/2J * DU6i)
abnormal abdominal fat pad morphology J:66233
Afpq11DBA/2/Afpq11DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afpq11DU6i/Afpq11DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw1DU6/Afw1DU6
(involves: DU6 * DUKs)
abnormal abdominal fat pad morphology J:49578
Afw2DU6/Afw2DU6
(involves: DU6 * DUKs)
abnormal abdominal fat pad morphology J:49578
Afw3DU6/Afw3DU6
(involves: DU6 * DUKs)
abnormal abdominal fat pad morphology J:49578
Afw5DU6/Afw5DU6
(involves: DU6 * DUKs)
abnormal abdominal fat pad morphology J:49578
Afw9DU6i/?
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw12DBA/2/Afw12DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw12DU6i/Afw12DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw13PWK/Afw13PWK
(involves: C57BL/6 * PWK)
abnormal abdominal fat pad morphology J:152067
Afw14DBA/2/Afw14DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw14DU6i/Afw14DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw15DU6i/?
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw16C57BL/6/Afw16C57BL/6
(involves: C57BL/6 * PWK)
abnormal abdominal fat pad morphology J:152067
Afw17DBA/2/Afw17DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw18DBA/2/Afw18DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw18DU6i/Afw18DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw19DBA/2/Afw19DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Afw19DU6i/Afw19DU6i
(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:66233
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6)
abnormal epididymal fat pad morphology J:250301
decreased percent body fat/body weight J:250301
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal brown adipose tissue morphology J:186035
abnormal white fat cell morphology J:186035
adipose tissue inflammation J:186035
adipose tissue necrosis J:186035
decreased brown adipose tissue amount J:186035
decreased white adipose tissue amount J:186035
decreased white fat cell number J:186035
decreased white fat cell size J:186035
lipodystrophy J:186035
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
abnormal abdominal fat pad morphology J:146649
absent subcutaneous adipose tissue J:146649
decreased brown adipose tissue amount J:146649
decreased percent body fat/body weight J:146649
decreased total body fat amount J:146649
decreased white adipose tissue amount J:146649
Agpat4tm1b(KOMP)Wtsi/Agpat4tm1b(KOMP)Wtsi
(C57BL/6N-Agpat4tm1b(KOMP)Wtsi/H)
increased total body fat amount J:211773
Agr2tm1.1Lex/Agr2tm1.1Lex
(involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6)
decreased total fat pad weight J:195573
Agrptm1(cre)Lowl/Agrp+
Slc32a1tm1Lowl/Slc32a1tm1Lowl

(involves: 129S6/SvEvTac * C57BL/6)
decreased total body fat amount J:140858
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:199803
Agrptm1Mws/Agrptm1Mws
(B6.129S1-Agrptm1Mws)
decreased total body fat amount J:117539
Agttm1.1Itl/Agttm1.1Itl
Tg(Fabp4-cre)1Rev/0

(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
adipose tissue phenotype J:178836
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA * ICR)
decreased epididymal fat pad weight J:73163
decreased fat cell size J:73163
decreased total body fat amount J:73163
Agtr1atm1.1Uky/Agtr1atm1.1Uky
Tg(Fabp4-cre)1Rev/0

(involves: C57BL/6 * C57BL/6N * SJL)
abnormal adipose tissue development J:192945
adipose tissue phenotype J:192945
decreased white fat cell number J:192945
increased white fat cell size J:192945
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
abnormal epididymal fat pad morphology J:105210
decreased white fat cell size J:105210
increased white fat cell number J:105210
Ahcyl1tm1a(EUCOMM)Wtsi/Ahcyl1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ahcyl1tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Ahnaktm1Ysb/Ahnaktm1Ysb
(involves: 129S4/SvJae)
decreased total body fat amount J:167048
AI837181tm1b(KOMP)Wtsi/AI837181tm1b(KOMP)Wtsi
(C57BL/6N-AI837181tm1b(KOMP)Wtsi/Bay)
decreased total body fat amount J:211773
Akap9tm1a(KOMP)Wtsi/Akap9+
(B6JTyr;B6N-Akap9tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:175295
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N)
decreased percent body fat/body weight J:213427
decreased total body fat amount J:213427
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129)
abnormal white adipose tissue physiology J:208505
increased gonadal fat pad weight J:208505
increased inguinal fat pad weight J:208505
increased white adipose tissue amount J:208505
increased white fat cell size J:208505
Akt1tm1Mbb/Akt1tm1Mbb
(B6.129P2-Akt1tm1Mbb)
decreased percent body fat/body weight J:182721
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
decreased percent body fat/body weight J:149156
decreased white adipose tissue amount J:149156
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
decreased percent body fat/body weight J:182721
decreased total body fat amount J:182721
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
decreased adipocyte glucose uptake J:71491
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg)
decreased brown adipose tissue mass J:84606
decreased white adipose tissue mass J:84606
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
(C57BL/6N-Aktiptm1a(EUCOMM)Hmgu)
decreased subcutaneous adipose tissue amount J:276210
decreased total body fat amount J:276210
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Tcp)
increased total body fat amount J:211773
Aldh18a1tm1a(KOMP)Wtsi/Aldh18a1+
(C57BL/6N-Aldh18a1tm1a(KOMP)Wtsi/Wtsi)
abnormal hypodermis fat layer morphology J:232539
Aldobtm2b(EUCOMM)Wtsi/Aldobtm2b(EUCOMM)Wtsi
(C57BL/6N-Aldobtm2b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Alg2tm1.1(KOMP)Vlcg/Alg2+
(B6N(Cg)-Alg2tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Alg9em1(IMPC)J/Alg9+
(C57BL/6NJ-Alg9em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Alg10btm1.1(KOMP)Vlcg/Alg10b+
(C57BL/6N-Alg10btm1.1(KOMP)Vlcg/Bay)
decreased total body fat amount J:211773
Alg13tm1a(KOMP)Wtsi/Alg13tm1a(KOMP)Wtsi
(C57BL/6N-Alg13tm1a(KOMP)Wtsi/Wtsi)
increased total body fat amount J:211773
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
increased white adipose tissue amount J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD)
increased fat cell size J:118221
increased total body fat amount J:118221
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J)
increased total fat pad weight J:104825
Alpk2em1(IMPC)J/Alpk2em1(IMPC)J
(C57BL/6NJ-Alpk2em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
decreased total body fat amount J:39015
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ)
decreased total body fat amount J:90370
Amer1tm1.1Nbar/Y
Tg(Prrx1-cre)1Cjt/0

(involves: 129S4/SvJae * C57BL/6 * SJL)
abnormal fat cell differentiation J:173242
abnormal fat cell morphology J:173242
Amer1tm1.2Nbar/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL)
decreased brown adipose tissue amount J:173242
decreased total body fat amount J:173242
decreased white adipose tissue amount J:173242
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo)
decreased subcutaneous adipose tissue amount J:152387
decreased total body fat amount J:152387
Angptl3hypl/Angptl3hypl
(involves: KK/Snk)
decreased gonadal fat pad weight J:75358
Angptl3tm1Akos/Angptl3tm1Akos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
adipose tissue phenotype J:103363
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj)
decreased epididymal fat pad weight J:107479
Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:103363
Angptl4tm1Jig/Angptl4+
(involves: 129/Sv * C57BL/6)
decreased total body fat amount J:93455
Angptl4tm1Jig/Angptl4tm1Jig
(involves: 129/Sv * C57BL/6)
abnormal adipose tissue physiology J:93455
decreased total body fat amount J:93455
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal white adipose tissue morphology J:97552
increased total body fat amount J:97552
Angptl8tm1(KOMP)Vlcg/Angptl8tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
decreased percent body fat/body weight J:217262
decreased total body fat amount J:217262
Ank2tm1Bnt/Ank2+
(involves: 129)
abnormal fat cell differentiation J:222913
decreased adipocyte glucose uptake J:222913
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
abnormal fat cell differentiation J:222913
increased adipocyte glucose uptake J:222913
increased epididymal fat pad weight J:222913
increased fat cell size J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
abnormal fat cell differentiation J:222913
decreased adipocyte glucose uptake J:222913
increased adipocyte glucose uptake J:222913
increased epididymal fat pad weight J:222913
increased fat cell size J:222913
increased total body fat amount J:222913
Ankrd9tm1(KOMP)Wtsi/Ankrd9tm1(KOMP)Wtsi
(C57BL/6N-Ankrd9tm1(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6)
increased brown adipose tissue amount J:130984
increased fat cell size J:130984
increased white adipose tissue amount J:130984
Anks1btm1a(KOMP)Wtsi/Anks1btm1a(KOMP)Wtsi
(C57BL/6N-Anks1btm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Anks3em1(IMPC)J/Anks3+
(C57BL/6NJ-Anks3em1(IMPC)J/J)
decreased total body fat amount J:211773
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified)
abnormal adipose tissue morphology J:115806
abnormal adipose tissue physiology J:115806
abnormal fat pad morphology J:115806
Ap1artm2b(EUCOMM)Hmgu/Ap1artm2b(EUCOMM)Hmgu
(C57BL/6N-Ap1artm2b(EUCOMM)Hmgu/Bay)
decreased total body fat amount J:211773
Ap1g1tm1b(EUCOMM)Hmgu/Ap1g1+
(B6N(Cg)-Ap1g1tm1b(EUCOMM)Hmgu/J)
increased total body fat amount J:211773
Ap1s2tm1Pschu/Y
(involves: 129P2/OlaHsd * C57BL/6)
abnormal adipose tissue development J:216244
abnormal fat cell differentiation J:216244
abnormal interscapular fat pad morphology J:216244
decreased epididymal fat pad weight J:216244
decreased subcutaneous adipose tissue amount J:216244
decreased total body fat amount J:216244
lipodystrophy J:216244
Ap1s2tm1Pschu/Ap1s2tm1Pschu
(involves: 129P2/OlaHsd * C57BL/6)
abnormal adipose tissue development J:216244
abnormal fat cell differentiation J:216244
abnormal interscapular fat pad morphology J:216244
decreased subcutaneous adipose tissue amount J:216244
decreased total body fat amount J:216244
lipodystrophy J:216244
Ap4e1em1(IMPC)J/Ap4e1em1(IMPC)J
(C57BL/6NJ-Ap4e1em1(IMPC)J/J)
decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Bay)
decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ucd)
decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Orl)
decreased total body fat amount J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/MbpMmucd)
decreased total body fat amount J:211773
Ap4m1tm1b(EUCOMM)Wtsi/Ap4m1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap4m1tm1b(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Apbb2tm1.1(KOMP)Vlcg/Apbb2+
(C57BL/6N-Apbb2tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
ApcMin/Apc+
Il6tm1Kopf/Il6tm1Kopf

(involves: 129S2/SvPas * C57BL/6)
adipose tissue phenotype J:130429
Aplp2tm2b(EUCOMM)Hmgu/Aplp2tm2b(EUCOMM)Hmgu
(C57BL/6N-Aplp2tm2b(EUCOMM)Hmgu/Bay)
decreased total body fat amount J:211773
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs)
abnormal white adipose tissue morphology J:247647
abnormal white adipose tissue physiology J:247647
decreased brown adipose tissue mass J:247647
decreased white adipose tissue mass J:247647
decreased white fat cell size J:247647
increased white fat cell number J:247647
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J)
increased white adipose tissue amount J:105136
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0

(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
decreased epididymal fat pad weight J:219838
decreased white fat cell lipid droplet size J:219838
decreased white fat cell size J:219838
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
decreased brown adipose tissue mass J:60585
decreased epididymal fat pad weight J:60585
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi

(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
abnormal gonadal fat pad morphology J:184647
increased fat cell size J:184647
Apoetm1Unc/Apoetm1Unc
Gofm1C57BL/6J/?

(involves: C3H/HeJ * C57BL/6J)
abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm2C3H/HeJ/?

(involves: C3H/HeJ * C57BL/6J)
abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm2C57BL/6J/?

(involves: C3H/HeJ * C57BL/6J)
abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm3C57BL/6J/?

(involves: C3H/HeJ * C57BL/6J)
abnormal gonadal fat pad morphology J:115779
Apoetm1Unc/Apoetm1Unc
Gofm4C3H/HeJ/?

(involves: C3H/HeJ * C57BL/6J)
abnormal gonadal fat pad morphology J:115779
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6)
abnormal epididymal fat pad morphology J:151284
abnormal fat cell morphology J:151284
Appl1Gt(RRS819)Byg/Appl1Gt(RRS819)Byg
(involves: 129P2/OlaHsd * C57BL/6)
abnormal brown adipose tissue physiology J:211794
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H)
decreased total body fat amount J:211773
Aqp7tm1Ask/Aqp7tm1Ask
(involves: CD-1)
abnormal white adipose tissue physiology J:98734
increased fat cell size J:98734
increased gonadal fat pad weight J:98734
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
adipose tissue phenotype J:125011
Artm1(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
increased percent body fat/body weight J:108849
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0

(involves: 129S/SvEv * C57BL/6J * FVB/N)
abnormal fat cell morphology J:81789, J:98775
increased gonadal fat pad weight J:98775
increased renal fat pad weight J:98775
increased white adipose tissue amount J:98775
Artm1Ska/Y
Tg(CMV-cre)1Ipc/?

(involves: C57BL/6 * CBA)
increased white adipose tissue amount J:85484
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal adipose tissue amount J:196857
decreased gonadal fat pad weight J:196857
increased brown adipose tissue amount J:196857
increased interscapular fat pad weight J:196857
increased mesenteric fat pad weight J:196857
increased omental fat pad weight J:196857
Artm3(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
increased percent body fat/body weight J:108849
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
adipose tissue phenotype J:216529
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6)
absent subcutaneous adipose tissue J:119516
Arhgap5tm1Jset/Arhgap5tm1Jset
(involves: 129S2/SvPas * C57BL/6J)
abnormal adipose tissue physiology J:83120
decreased subcutaneous adipose tissue amount J:83120
Arhgef11tm1.1Mak/Arhgef11tm1.1Mak
(B6.129P2(C)-Arhgef11tm1.1Mak)
abnormal white adipose tissue physiology J:233950
abnormal white fat cell differentation J:233950
decreased percent body fat/body weight J:233950
decreased white adipose tissue mass J:233950
decreased white fat cell number J:233950
Arid4btm1b(EUCOMM)Wtsi/Arid4b+
(C57BL/6N-Arid4btm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Arid5btm1Whit/Arid5b+
(involves: 129S1/Sv * C57BL/6J)
decreased percent body fat/body weight J:130390
decreased white adipose tissue amount J:130390
Arid5btm1Whit/Arid5btm1Whit
(involves: 129S1/Sv * C57BL/6J)
abnormal adipose tissue morphology J:130390
decreased brown adipose tissue amount J:130390
decreased brown fat lipid droplet number J:130390
decreased percent body fat/body weight J:130390
decreased white adipose tissue amount J:130390
Arid5btm1Whit/Arid5btm1Whit
(involves: 129S1/Sv)
abnormal fat cell morphology J:130274
Arl4atm1Asch/Arl4atm1Asch
(involves: C57BL/6J)
adipose tissue phenotype J:75778
Arl6tm2Vcs/Arl6tm2Vcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased percent body fat/body weight J:180524
Arl10tm1.1(KOMP)Vlcg/Arl10tm1.1(KOMP)Vlcg
(C57BL/6N-Arl10tm1.1(KOMP)Vlcg/Ucd)
increased total body fat amount J:211773
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr)
increased total body fat amount J:268298
Arntltm1.2Shbi/Arntltm1.2Shbi
(involves: C57BL/6J)
decreased total body fat amount J:177865
decreased white fat cell size J:177865
Arntltm1Bra/Arntltm1Bra
(involves: 129)
increased total fat pad weight J:115188
Arntltm1Bra/Arntltm1Bra
(B6.129-Arntltm1Bra)
decreased abdominal adipose tissue amount J:110697
decreased subcutaneous adipose tissue amount J:110697
decreased total body fat amount J:110697
Arpc2tm1a(EUCOMM)Wtsi/Arpc2+
(B6JTyr;B6N-Arpc2tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
Arrb1tm1b(KOMP)Wtsi/Arrb1tm1b(KOMP)Wtsi
(B6N(Cg)-Arrb1tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Arrb2tm1.1(KOMP)Vlcg/Arrb2tm1.1(KOMP)Vlcg
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Arrdc1tm1.1(KOMP)Vlcg/Arrdc1tm1.1(KOMP)Vlcg
(B6N(Cg)-Arrdc1tm1.1(KOMP)Vlcg/J)
increased total body fat amount J:211773
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6)
abnormal brown fat cell morphology J:179646
decreased gonadal fat pad weight J:179646
decreased percent body fat/body weight J:179646
decreased white fat cell size J:179646
Arsbm1J/Arsbm1J
(C57BL/6J-Arsbm1J/GrsrJ)
decreased percent body fat/body weight J:149960
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J)
decreased body fat mass J:263695
decreased brown adipose tissue amount J:263695
decreased epididymal fat pad weight J:263695
decreased inguinal fat pad weight J:263695
decreased mesenteric fat pad weight J:263695
decreased retroperitoneal fat pad weight J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
adipose tissue phenotype J:241193
decreased body fat mass J:241193
decreased percent body fat/body weight J:241193
decreased subcutaneous adipose tissue amount J:241193
decreased white adipose tissue amount J:241193
decreased white fat cell size J:241193
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
decreased gonadal fat pad weight J:232306
Asap1Gt(RRS873)Byg/Asap1Gt(RRS873)Byg
(FVB.129P2(B6)-Asap1Gt(RRS873)Byg)
abnormal adipose tissue development J:277387
abnormal fat cell differentiation J:277387
decreased gonadal fat pad weight J:277387
decreased retroperitoneal fat pad weight J:277387
decreased white fat cell number J:277387
decreased white fat cell size J:277387
Ash1lGt(AL0395)Wtsi/Ash1lGt(AL0395)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J)
decreased abdominal adipose tissue amount J:227516
Aspatm1Mata/Aspatm1Mata
(involves: 129S5/SvEvBrd)
decreased total body fat amount J:89099
Aspmtm1a(KOMP)Wtsi/Aspmtm1a(KOMP)Wtsi
(C57BL/6N-Aspmtm1a(KOMP)Wtsi/Wtsi)
increased total body fat amount J:211773
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S1/Sv * C57BL/6 * CBA)
abnormal white adipose tissue physiology J:155421
decreased abdominal adipose tissue amount J:155421
decreased brown fat cell size J:155421
decreased white adipose tissue amount J:155421
decreased white fat cell size J:155421
Atf2tm1Sis/Atf2+
Creb5tm1Sis/Creb5+

(involves: C57BL/6 * CBA)
adipose tissue phenotype J:156376
decreased subcutaneous adipose tissue amount J:156376
decreased white adipose tissue amount J:156376
decreased white fat cell size J:156376
Atf3tm1.2Kitab/Atf3tm1.2Kitab
Tg(Pdx1-cre)89.1Dam/0

(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)
abnormal white adipose tissue physiology J:231262
abnormal white fat cell morphology J:231262
decreased abdominal adipose tissue amount J:231262
decreased epididymal fat pad weight J:231262
decreased inguinal fat pad weight J:231262
decreased subcutaneous adipose tissue amount J:231262
decreased white adipose tissue amount J:231262
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
decreased total fat pad weight J:152695
Atg5tm1Myok/Atg5tm1Myok
Tg(Pomc1-cre)1Gsb/0

(involves: 129S/SvEv * C57BL/6 * FVB/N)
adipose tissue phenotype J:232686
Atg12tm1.1Jdth/Atg12tm1.1Jdth
Tg(Pomc1-cre)1Gsb/0

(involves: C57BL/6 * FVB/N)
adipose tissue phenotype J:232686
increased body fat mass J:232686
increased total body fat amount J:232686
Atl2tm2b(EUCOMM)Hmgu/Atl2+
(C57BL/6N-Atl2tm2b(EUCOMM)Hmgu/H)
increased total body fat amount J:211773
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc)
abnormal adipose tissue distribution J:222034
abnormal fat cell differentiation J:222034
decreased subcutaneous adipose tissue amount J:222034
Atn1tm1b(EUCOMM)Wtsi/Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm)
decreased total body fat amount J:211773
Atp5mdtm1b(EUCOMM)Wtsi/Atp5mdtm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mdtm1b(EUCOMM)Wtsi/H)
decreased total body fat amount J:211773
Atp6v0a1tm1b(EUCOMM)Hmgu/Atp6v0a1+
(C57BL/6N-Atp6v0a1tm1b(EUCOMM)Hmgu/Tcp)
decreased total body fat amount J:211773
Atp7atm1.1Mjp/Y
Mnx1tm4(cre)Tmj/Mnx1+

(involves: 129S1/Sv * C57BL/6)
abnormal gonadal fat pad morphology J:221066
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
decreased total body fat amount J:211773
Atp8b2tm1a(KOMP)Wtsi/Atp8b2tm1a(KOMP)Wtsi
(C57BL/6N-Atp8b2tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Atpif1tm1a(EUCOMM)Wtsi/Atpif1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atpif1tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
decreased subcutaneous adipose tissue amount J:123200
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J)
decreased total body fat amount J:71075
Atrnmg/Atrnmg
(C3H/HeJ.Cg-Atrnmg)
decreased total body fat amount J:71075
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
increased gonadal fat pad weight J:135320
Atxn2tm1Plt/Atxn2tm1Plt
(involves: 129X1/SvJ * C57BL/6)
abnormal abdominal fat pad morphology J:103805
AU040320em1(IMPC)J/AU040320em1(IMPC)J
(C57BL/6NJ-AU040320em1(IMPC)J/J)
increased total body fat amount J:211773
Auts2em1(IMPC)Wtsi/Auts2+
(C57BL/6N-Auts2em1(IMPC)Wtsi/Wtsi)
decreased total body fat amount J:211773
Azgp1tm1.1Sbah/Azgp1tm1.1Sbah
(involves: 129P2/OlaHsd * C57BL/6)
abnormal adipose tissue physiology J:118213
B3galnt2em1(IMPC)J/B3galnt2+
(C57BL/6NJ-B3galnt2em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
B4galt1tm1Shur/B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J)
decreased subcutaneous adipose tissue amount J:37846
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
decreased gonadal fat pad weight J:144416
decreased subcutaneous adipose tissue amount J:144416
Batq1MH/?
(involves: C57BL/6J * MH)
increased brown adipose tissue amount J:55483
Batq2MH/Batq2C57BL/6J
(involves: C57BL/6J * MH)
increased brown adipose tissue amount J:55483
Batq2MH/Batq2MH
(involves: C57BL/6J * MH)
increased brown adipose tissue amount J:55483
Bbs1tm1Vcs/Bbs1tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ)
abnormal fat pad morphology J:128532
increased brown adipose tissue amount J:128532
increased total body fat amount J:128532
Bbs2tm1Vcs/Bbs2tm1Vcs
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
abnormal abdominal fat pad morphology J:94467
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd)
increased abdominal adipose tissue amount J:134093
Bbs4tm1Vcs/Bbs4tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
increased total body fat amount J:90812
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
increased total body fat amount J:211773
Bbs9m1Btlr/Bbs9m1Btlr
(C57BL/6J-Bbs9m1Btlr)
increased body fat mass J:265189
Bbs10tm1.2Vmar/Bbs10tm1.2Vmar
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:227230
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6)
abnormal fat cell morphology J:189019
increased adipocyte glucose uptake J:189019
increased epididymal fat pad weight J:189019
increased fat cell size J:189019
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N)
decreased epididymal fat pad weight J:129967
decreased percent body fat/body weight J:129967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0

(involves: C57BL/6N * FVB)
abnormal brown adipose tissue physiology J:278806
increased total body fat amount J:278806
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex)
decreased total body fat amount J:117564
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk
Tg(CAG-EGFP/Map1lc3b)53Nmz/0

(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
abnormal percent body fat/body weight J:181308
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(ACTA1-rtTA,tetO-cre)102Monk/0

(involves: C3H * C57BL/6)
increased body fat mass J:271078
increased white adipose tissue amount J:271078
increased white fat cell size J:271078
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6 * FVB/NJ)
abnormal gonadal fat pad morphology J:271078
adipose tissue inflammation J:271078
decreased adipocyte glucose uptake J:271078
increased adipocyte glucose uptake J:271078
increased body fat mass J:271078
increased subcutaneous adipose tissue amount J:271078
increased white fat cell size J:271078
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
abnormal adipose tissue morphology J:170742
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
Ins2Akita/Ins2+

(B6.Cg-Ins2Akita Bdkrb2tm1Jfh)
decreased subcutaneous adipose tissue amount J:108948
Bdt3DBA/2J/Bdt3DBA/2J
(involves: C57BL/6J * DBA/2J)
increased total fat pad weight J:104825
Bdwtq129S1/SvImJ/Bdwtq129S1/SvImJ
(C57BL/6J-Chr 7129S1/SvImJ)
abnormal fat pad morphology J:131438
decreased gonadal fat pad weight J:131438
decreased inguinal fat pad weight J:131438
decreased mesenteric fat pad weight J:131438
decreased retroperitoneal fat pad weight J:131438
Bfq1LP/J/Bfq1LP/J
(involves: C57BL/10SnJ * LP/J)
decreased percent body fat/body weight J:42700
decreased retroperitoneal fat pad weight J:42700
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
abnormal fat cell morphology J:126780
decreased adipocyte glucose uptake J:126780
increased total body fat amount J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
abnormal fat cell morphology J:126780
decreased adipocyte glucose uptake J:126780
increased total body fat amount J:126780
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(B6N(Cg)-Bhlhe40tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Bhmttm1b(EUCOMM)Hmgu/Bhmttm1b(EUCOMM)Hmgu
(C57BL/6N-Bhmttm1b(EUCOMM)Hmgu/Bay)
decreased total body fat amount J:211773
Bmncrtm1.1Xhl/Bmncrtm1.1Xhl
(Not Specified)
increased bone marrow adipose tissue amount J:270992
Bmp1tm1.1Dgr/Bmp1tm1.1Dgr
Tll1tm2.1Dgr/Tll1tm2.1Dgr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL)
decreased gonadal fat pad weight J:210366
decreased inguinal fat pad weight J:210366
Bnip2tm1b(EUCOMM)Wtsi/Bnip2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bnip2tm1b(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Bntq1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
increased white adipose tissue amount J:95898
Borcs6tm1.1(KOMP)Vlcg/Borcs6+
(B6N(Cg)-Borcs6tm1.1(KOMP)Vlcg/J)
increased total body fat amount J:211773
Bpiem1(IMPC)J/Bpiem1(IMPC)J
(C57BL/6NJ-Bpiem1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
decreased white adipose tissue amount J:170095
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
decreased white adipose tissue amount J:170095
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd)
decreased white adipose tissue amount J:170095
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53+

(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB)
decreased subcutaneous adipose tissue amount J:81559
decreased total body fat amount J:81559
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
decreased subcutaneous adipose tissue amount J:155810
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
abnormal adipose tissue morphology J:159964
increased epididymal fat pad weight J:159964
increased fat cell size J:159964
increased interscapular fat pad weight J:159964
increased total body fat amount J:159964
Brs3tm1Hoh/Brs3tm1Hoh
(involves: 129P2/OlaHsd * C57BL/6J)
increased white adipose tissue amount J:44242
Brs3tm1Jfb/Brs3tm1Jfb
(B6.129X1-Brs3tm1Jfb)
abnormal epididymal fat pad morphology J:134021
adipose tissue phenotype J:134021
increased brown adipose tissue amount J:134021
increased white adipose tissue amount J:134021
Brs3tm1Lex/Brs3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
increased percent body fat/body weight J:185494
Bsbob2SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
abnormal white adipose tissue amount J:90614
increased percent body fat/body weight J:90614
Bsbob4SPRET/EiJ/?
Bsbob5C57BL/6J/?

(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
increased percent body fat/body weight J:90614
Bsbob5SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
decreased percent body fat/body weight J:90614
BsbobC57BL/6J/BsbobSPRET/EiJ
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
decreased gonadal fat pad weight J:90700
decreased percent body fat/body weight J:90614
decreased retroperitoneal fat pad weight J:90700
decreased total body fat amount J:90700, J:90614
decreased white adipose tissue amount J:90700
BsbobSPRET/EiJ/BsbobSPRET/EiJ
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
abnormal epididymal fat pad morphology J:127206
abnormal fat pad morphology J:127206
decreased gonadal fat pad weight J:90700
decreased percent body fat/body weight J:90614
decreased retroperitoneal fat pad weight J:90700
decreased total body fat amount J:127206, J:90700, J:90614
decreased white adipose tissue amount J:90700
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Ddx4-cre)1Dcas/0

(involves: 129 * 129S4/SvJaeSor * FVB/N)
adipose tissue phenotype J:211072
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Fabp4-cre)1Rev/0

(involves: 129 * 129S4/SvJaeSor)
lipodystrophy J:211072
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal epididymal fat pad morphology J:211142
abnormal fat cell differentiation J:183701
abnormal fat pad morphology J:183701
abnormal white adipose tissue amount J:183701
abnormal white adipose tissue morphology J:211142
abnormal white adipose tissue physiology J:211142
abnormal white fat cell morphology J:183701
decreased brown adipose tissue amount J:183701
decreased gonadal fat pad weight J:183701
decreased interscapular fat pad weight J:183701
decreased renal fat pad weight J:183701
decreased subcutaneous adipose tissue amount J:183701
decreased total body fat amount J:183701
decreased white adipose tissue amount J:211142
decreased white fat cell number J:183701
decreased white fat cell size J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
abnormal epididymal fat pad morphology J:173404
abnormal hypodermis fat layer morphology J:173404
abnormal white fat cell differentation J:173404
decreased brown adipose tissue amount J:173404
decreased gonadal fat pad weight J:173404
decreased inguinal fat pad weight J:173404
decreased mesenteric fat pad weight J:173404
decreased retroperitoneal fat pad weight J:173404
decreased subcutaneous adipose tissue amount J:173404
decreased total body fat amount J:173404
lipodystrophy J:211072
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
decreased total body fat amount J:211773
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6N * FVB/NJ)
abnormal brown adipose tissue morphology J:260853
abnormal infrapatellar fat pad morphology J:260853
abnormal white adipose tissue morphology J:260853
browned white adipose tissue morphology J:260853
decreased body fat mass J:260853
decreased bone marrow adipose tissue amount J:260853
decreased brown adipose tissue mass J:260853
decreased subcutaneous adipose tissue amount J:260853
decreased white adipose tissue amount J:260853
lipodystrophy J:260853
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno)
abnormal adipose tissue development J:200947
decreased gonadal fat pad weight J:200947
decreased inguinal fat pad weight J:200947
decreased interscapular fat pad weight J:200947
decreased mesenteric fat pad weight J:200947
increased brown adipose tissue amount J:200947
lipodystrophy J:200947
Bsxtm1Tre/Bsxtm1Tre
(B6.129-Bsxtm1Tre)
increased percent body fat/body weight J:122746
Btbd16tm2b(EUCOMM)Hmgu/Btbd16tm2b(EUCOMM)Hmgu
(C57BL/6N-Btbd16tm2b(EUCOMM)Hmgu/Bay)
decreased total body fat amount J:211773
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac)
decreased subcutaneous adipose tissue amount J:91128
decreased total body fat amount J:91128
Bub1btm2.1Jvd/Bub1b+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
abnormal fat pad morphology J:194926
decreased fat cell size J:194926
decreased inguinal fat pad weight J:194926
decreased mesenteric fat pad weight J:194926
decreased subcutaneous adipose tissue amount J:194926
decreased total body fat amount J:194926
Bub3tm1Jvd/Bub3+
Rae1tm1Jvd/Rae1+

(Not Specified)
decreased subcutaneous adipose tissue amount J:105717
decreased total body fat amount J:105717
Bvestm1.1(KOMP)Vlcg/Bvestm1.1(KOMP)Vlcg
(C57BL/6N-Bvestm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J)
decreased total body fat amount J:211773
C1qbtm1.1(KOMP)Vlcg/C1qbtm1.1(KOMP)Vlcg
(B6N(Cg)-C1qbtm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex)
decreased body fat mass J:241403
decreased gonadal fat pad weight J:241403
decreased subcutaneous adipose tissue amount J:241403
C1qtnf2tm1Lex/C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex)
decreased body fat mass J:282612
decreased epididymal fat pad weight J:282612
decreased inguinal fat pad weight J:282612
decreased white adipose tissue amount J:282612
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
adipose tissue phenotype J:237401
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
adipose tissue phenotype J:212299
increased percent body fat/body weight J:212299
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6)
decreased total body fat amount J:58966, J:60633
decreased white adipose tissue amount J:60633
increased brown adipose tissue amount J:58966
C3tm1Hrc/C3tm1Hrc
(involves: 129)
decreased total body fat amount J:87945
C3ar1tm1Dgen/C3ar1tm1Dgen
(involves: 129P2/OlaHsd)
abnormal fat pad morphology J:148831
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6)
abnormal adipose tissue physiology J:123294
abnormal fat cell morphology J:123294
Cacna1smdg/Cacna1smdg
(involves: STOCK T/t4)
increased brown adipose tissue amount J:14970
Cadtm1c(KOMP)Wtsi/Cadtm1c(KOMP)Wtsi
Tg(Adipoq-rtTA)2Zvw/0
Tg(tetO-cre)1Jaw/0

(involves: 129 * C57BL/6 * C57BL/6N)
decreased white fat cell size J:260830
Cadtm1c(KOMP)Wtsi/Cadtm1c(KOMP)Wtsi
Tg(Adipoq-rtTA)2Zvw/0
Tg(tetO-cre)1Jaw/0
Tg(tetO-Xbp1_is)#Pesch/0

(involves: 129 * C57BL/6 * C57BL/6N * FVB/N)
adipose tissue phenotype J:260830
Calm1em1Gkim/Calm1em1Gkim
(C57BL/6N-Calm1em1Gkim)
increased body fat mass J:272366
Camk2btm1.1Ics/Camk2b+
(B6J.129S2(Cg)-Camk2btm1.1Ics)
increased percent body fat/body weight J:219040
Camk2btm1.1Ics/Camk2btm1.1Ics
(B6J.129S2(Cg)-Camk2btm1.1Ics)
increased percent body fat/body weight J:219040
Camkk2tm1.1Arm/Camkk2tm1.1Arm
(involves: C57BL/6)
decreased total body fat amount J:136219
increased brown adipose tissue amount J:136219
increased percent body fat/body weight J:136219
Camkmttm1b(EUCOMM)Wtsi/Camkmttm1b(EUCOMM)Wtsi
(C57BL/6N-Camkmttm1b(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Carfhg1CAST/EiJ/?
(involves: CAST/EiJ * C57BL/6J-Socs2hg)
increased total body fat amount J:68441
Carfhg2CAST/EiJ/?
(involves: CAST/EiJ * C57BL/6J-Socs2hg)
increased total body fat amount J:68441
Carfhg2CAST/EiJ/Carfhg2CAST/EiJ
(involves: CAST/EiJ * C57BL/6J-Socs2hg)
increased total body fat amount J:111441
Carm1tm1Mtb/Carm1tm1Mtb
(involves: 129S6/SvEvTac)
abnormal adipose tissue development J:159958
Carm1tm2.1Mtb/Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)
abnormal adipose tissue development J:159958
Carp2CAST/EiJ/Carp2CAST/EiJ
(involves: C57BL/6J-Socs2hg * CAST/EiJ)
increased percent body fat/body weight J:111441
increased total fat pad weight J:111441
Cartpttm1Hmh/Cartpt+
(involves: 129P2/OlaHsd * C57BL/6)
increased total body fat amount J:97913
Cartpttm1Hmh/Cartpttm1Hmh
(involves: 129P2/OlaHsd * C57BL/6)
increased total body fat amount J:97913
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
abnormal fat cell morphology J:75192
abnormal gonadal fat pad morphology J:75192
abnormal mammary fat pad morphology J:75192
absent subcutaneous adipose tissue J:75192
decreased subcutaneous adipose tissue amount J:75192
decreased total body fat amount J:75192
decreased white adipose tissue amount J:75192
decreased white fat cell lipid droplet size J:75192
increased brown adipose tissue amount J:75192
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
abnormal fat cell morphology J:89326
Cav1tm1Mls/Cav1tm1Mls
(B6.Cg-Cav1tm1Mls)
abnormal brown fat cell morphology J:105133
abnormal fat cell morphology J:205741
increased brown fat cell lipid droplet size J:105133
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
abnormal adipose tissue physiology J:182288
decreased total body fat amount J:182288
Cav2tm1Mls/Cav2tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
adipose tissue phenotype J:75490
Cavin2tm1(KOMP)Vlcg/Cavin2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
abnormal fat cell morphology J:205741
Cavin3tm1Pemi/Cavin3tm1Pemi
(B6.129S4-Cavin3tm1Pemi)
lipodystrophy J:202374
Cbltm1Ddlb/Cbl+
(involves: 129S1/Sv * C57BL/6)
decreased white adipose tissue amount J:94416
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6J)
abnormal mammary fat pad morphology J:76895
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
abnormal fat cell morphology J:94416
decreased total body fat amount J:94416
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6)
abnormal epididymal fat pad morphology J:121012
decreased brown adipose tissue amount J:121012
decreased total body fat amount J:121012
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Cby1tm1Ktkm/Cby1tm1Ktkm
(Not Specified)
abnormal fat cell differentiation J:122334
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm)
decreased subcutaneous adipose tissue amount J:147413
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J)
increased total body fat amount J:228688
Ccar2tm1Dac/Ccar2tm1Dac
Lepob/Lepob

(involves: 129 * C57BL/6J)
increased total body fat amount J:228688
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J)
abnormal fat pad morphology J:220560
decreased subcutaneous adipose tissue amount J:220560
decreased white fat cell size J:220560
Ccdc7aTg(Prnp-Sirt1)10Imai/?
(B6.Cg-Ccdc7aTg(Prnp-Sirt1)10Imai)
abnormal brown adipose tissue physiology J:203814
Ccdc8em1(IMPC)Tcp/Ccdc8+
(C57BL/6NCrl-Ccdc8em1(IMPC)Tcp/Tcp)
increased total body fat amount J:211773
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
increased total body fat amount J:189183
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
abnormal epididymal fat pad morphology J:110277
abnormal gonadal fat pad morphology J:126512
decreased fat cell size J:110277
increased percent body fat/body weight J:126512
increased total fat pad weight J:126512
Ccl25tm1Lex/Ccl25tm1Lex
(B6;129S5-Ccl25tm1Lex/Ieg)
increased total body fat amount J:172753, J:82809
Ccn3tm1.1Ecan/Ccn3tm1.1Ecan
(B6.Cg-Ccn3tm1.1Ecan)
adipose tissue phenotype J:158478
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H)
decreased total body fat amount J:211773
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6)
abnormal brown adipose tissue physiology J:224589
abnormal fat cell differentiation J:224589
abnormal fat pad morphology J:224589
adipose tissue phenotype J:224589
decreased inguinal fat pad weight J:224589
decreased renal fat pad weight J:224589
decreased retroperitoneal fat pad weight J:224589
decreased total body fat amount J:224589
decreased white fat cell size J:224589
Cd14tm1Frm/Cd14tm1Frm
(B6.129S4-Cd14tm1Frm)
decreased total body fat amount J:118467
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
abnormal fat pad morphology J:126461
decreased percent body fat/body weight J:126461
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
abnormal adipose tissue physiology J:220343
decreased adipocyte glucose uptake J:220343
decreased brown adipose tissue amount J:220343
Cd84tm1b(KOMP)Mbp/Cd84tm1b(KOMP)Mbp
(B6N(Cg)-Cd84tm1b(KOMP)Mbp/J)
decreased total body fat amount J:211773
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6)
abnormal fat cell morphology J:217719
Cd300lgtm1a(KOMP)Wtsi/Cd300lgtm1a(KOMP)Wtsi
(C57BL/6N-Cd300lgtm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Cdc73tm1Btt/Cdc73tm1Btt
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S4/SvJae * C57BL/6 * CBA)
decreased abdominal adipose tissue amount J:135255
decreased subcutaneous adipose tissue amount J:135255
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Cdk7Gt(D032B11)1.1Wrst/Cdk7Gt(D032B11)1.1Wrst
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvPas * 129S2/SvPas * C57BL/6 * SJL)
decreased subcutaneous adipose tissue amount J:183925
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
decreased abdominal fat pad weight J:195460
decreased subcutaneous adipose tissue amount J:195460
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas)
increased brown adipose tissue amount J:118516
increased inguinal fat pad weight J:118516
increased parametrial fat pad weight J:118516
increased white fat cell number J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako

(involves: 129S1/Sv * 129S2/SvPas)
increased brown adipose tissue amount J:118516
increased inguinal fat pad weight J:118516
increased parametrial fat pad weight J:118516
increased total body fat amount J:118516
increased white fat cell number J:118516
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv)
increased brown adipose tissue amount J:118516
increased inguinal fat pad weight J:118516
increased parametrial fat pad weight J:118516
increased white fat cell number J:118516
Cdkn1ctm1Sje/Cdkn1c+
(involves: 129S2/SvHsd * 129S7/SvEvBrd)
abnormal brown adipose tissue morphology J:232408
abnormal interscapular fat pad morphology J:232408
decreased brown adipose tissue amount J:232408
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
increased abdominal fat pad weight J:181979
increased total body fat amount J:181979
Cebpatm1.1(Cebpb)Ylee/Cebpatm1.1(Cebpb)Ylee
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
abnormal brown adipose tissue morphology J:77646
abnormal fat cell morphology J:77646
abnormal white adipose tissue morphology J:77646
decreased white adipose tissue amount J:77646
increased brown adipose tissue amount J:77646
Cebpatm1.1(Cebpb)Ylee/Cebpatm1.1Gonz
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
abnormal white adipose tissue morphology J:77646
decreased white adipose tissue amount J:77646
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal inguinal fat pad morphology J:28320
decreased brown adipose tissue amount J:28320
decreased white adipose tissue amount J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0

(involves: 129X1/SvJ * C57BL/6J * FVB/N)
abnormal fat cell morphology J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased brown adipose tissue amount J:35795
decreased white adipose tissue amount J:89611
Cebpatm1Nerl/Cebpatm1Nerl
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:72330
Cebpatm2Nerl/Cebpatm2Nerl
(involves: 129P2/OlaHsd * C57BL/6)
abnormal gonadal fat pad morphology J:72330
decreased white adipose tissue amount J:72330
Cebpatm3Nerl/Cebpatm3Nerl
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:72330
Cebpatm4Nerl/Cebpatm4Nerl
(involves: 129P2/OlaHsd * C57BL/6)
abnormal gonadal fat pad morphology J:72330
decreased white adipose tissue amount J:72330
Cebpatm5Nerl/Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:120098
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:120098
decreased adipocyte glucose uptake J:120098
Cebpbtm1Kish/Cebpbtm1Kish
(involves: 129P2/OlaHsd)
abnormal brown adipose tissue morphology J:45062
Cebpbtm1Kish/Cebpbtm1Kish
Cebpdtm1Aki/Cebpdtm1Aki

(involves: 129P2/OlaHsd)
abnormal brown adipose tissue thermogenesis J:45062
abnormal brown fat cell morphology J:45062
abnormal brown fat lipid droplet number J:45062
decreased epididymal fat pad weight J:45062
decreased white adipose tissue amount J:45062
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
abnormal adipose tissue physiology J:52286
decreased gonadal fat pad weight J:62132
decreased percent body fat/body weight J:62132
decreased uterine fat pad weight J:52286
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6)
abnormal brown adipose tissue physiology J:117502
decreased brown adipose tissue amount J:117502
decreased epididymal fat pad weight J:117502
Cebpdtm1Aki/Cebpdtm1Aki
(involves: 129P2/OlaHsd)
abnormal brown adipose tissue morphology J:45062
abnormal epididymal fat pad morphology J:45062
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased percent body fat/body weight J:124658
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cenpjtm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
Cep19tm1.1Jmgi/Cep19tm1.1Jmgi
(involves: 129S2/SvPas * C57BL/6J)
increased percent body fat/body weight J:206667
increased total body fat amount J:206667
Cep19tm1b(EUCOMM)Hmgu/Cep19tm1b(EUCOMM)Hmgu
(C57BL/6N-Cep19tm1b(EUCOMM)Hmgu/Bay)
increased total body fat amount J:211773
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac)
increased percent body fat/body weight J:206667
increased total body fat amount J:206667
Cep250tm1a(EUCOMM)Wtsi/Cep250tm1a(EUCOMM)Wtsi
(C57BL/6N-Cep250tm1a(EUCOMM)Wtsi/Wtsi)
increased total body fat amount J:211773
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N)
decreased brown fat cell lipid droplet size J:215519
decreased fat cell size J:215519
decreased total body fat amount J:215519
Ces1dtm1Rile/Ces1dtm1Rile
(involves: 129S6/SvEvTac)
increased white adipose tissue amount J:158743
increased white fat cell size J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6)
abnormal brown adipose tissue morphology J:262803
decreased brown adipose tissue mass J:262803
increased white adipose tissue mass J:262803
increased white fat cell size J:262803
Chadtm1Gast/Chadtm1Gast
(B6.129-Chadtm1Gast)
decreased total body fat amount J:203141
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
decreased white adipose tissue amount J:146743
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6J)
absent subcutaneous adipose tissue J:137079
decreased subcutaneous adipose tissue amount J:137079
Chd2tm1b(EUCOMM)Hmgu/Chd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Chd2tm1b(EUCOMM)Hmgu/Tcp)
decreased total body fat amount J:211773
Chd7Whi/Chd7+
(involves: C3HeB/FeJ)
decreased total body fat amount J:104123
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J)
decreased gonadal fat pad weight J:67919
Chrm3tm1Jwe/Chrm3tm1Jwe
(129S6/SvEvTac-Chrm3tm1Jwe)
decreased gonadal fat pad weight J:67919
Chsy3em2(IMPC)Mbp/Chsy3em2(IMPC)Mbp
(C57BL/6NCrl-Chsy3em2(IMPC)Mbp/Mmucd)
decreased total body fat amount J:211773
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ)
decreased brown adipose tissue mass J:85229
decreased white adipose tissue mass J:85229
decreased white fat cell size J:215366
Cidebtm1Pli/Cidebtm1Pli
(Not Specified)
abnormal fat pad morphology J:126556
abnormal white adipose tissue morphology J:126556
decreased total body fat amount J:126556
increased fat cell size J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?

(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel)
abnormal white adipose tissue morphology J:226899
abnormal white adipose tissue physiology J:226899
abnormal white fat cell morphology J:226899
decreased percent body fat/body weight J:226899
decreased white adipose tissue amount J:226899
decreased white fat cell size J:226899
increased adipocyte glucose uptake J:226899
increased brown adipose tissue amount J:226899
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka)
abnormal brown adipose tissue morphology J:140863
abnormal white adipose tissue morphology J:140863
decreased subcutaneous adipose tissue amount J:140863
decreased white adipose tissue amount J:140863
Cidectm1Pli/Cidectm1Pli
(Not Specified)
abnormal brown adipose tissue morphology J:140122
abnormal fat cell morphology J:140122
abnormal fat pad morphology J:140122
abnormal gonadal fat pad morphology J:140122
decreased gonadal fat pad weight J:140122
decreased inguinal fat pad weight J:140122
decreased mesenteric fat pad weight J:140122
decreased retroperitoneal fat pad weight J:140122
decreased subcutaneous adipose tissue amount J:140122
decreased total body fat amount J:140122
Cidectm1Pli/Cidectm1Pli
Lepob/Lepob

(involves: C57BL/10J)
abnormal adipose tissue amount J:140122
abnormal gonadal fat pad morphology J:140122
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
decreased subcutaneous adipose tissue amount J:148467
decreased total body fat amount J:148467
Ckbtm1.1(KOMP)Wtsi/Ckbtm1.1(KOMP)Wtsi
(C57BL/6N-Ckbtm1.1(KOMP)Wtsi/Ucd)
decreased total body fat amount J:211773
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal abdominal fat pad morphology J:80901
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
decreased total body fat amount J:211773
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
increased body fat mass J:279934
Cldn19tm1.1(KOMP)Vlcg/Cldn19tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn19tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Clec11aem1Sjm/Clec11aem1Sjm
(involves: C57BL/6 * C57BL/Ka)
abnormal fat cell morphology J:239391
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6)
decreased total body fat amount J:160186
Cln6tm1b(EUCOMM)Hmgu/Cln6tm1b(EUCOMM)Hmgu
(C57BL/6N-Cln6tm1b(EUCOMM)Hmgu/Tcp)
decreased total body fat amount J:211773
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt)
increased fat cell size J:98343
increased percent body fat/body weight J:98343
Clockm1Jt/Clockm1Jt
Lepob/Lepob

(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR)
increased fat cell size J:135847
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Clpstm1Lowe/Clpstm1Lowe
(involves: 129S6/SvEvTac * Black Swiss)
decreased percent body fat/body weight J:75167
Clrn2em1(IMPC)J/Clrn2em1(IMPC)J
(C57BL/6NJ-Clrn2em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6)
decreased percent body fat/body weight J:148522
Cluhtm1.1Eir/Cluhtm1.1Eir
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: BALB/cJ * C57BL/6 * DBA * SJL)
increased brown fat lipid droplet number J:249661
Cmtm5tm1a(KOMP)Wtsi/Cmtm5tm1a(KOMP)Wtsi
(C57BL/6N-Cmtm5tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Cnih3tm1a(KOMP)Wtsi/Cnih3tm1a(KOMP)Wtsi
(C57BL/6N-Cnih3tm1a(KOMP)Wtsi/Wtsi)
increased total body fat amount J:211773
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
decreased body fat mass J:180033
decreased brown fat cell size J:180033
decreased percent body fat/body weight J:180033
decreased subcutaneous adipose tissue amount J:180033
decreased white fat cell size J:180033
Cnot4tm1b(EUCOMM)Wtsi/Cnot4+
(C57BL/6N-Cnot4tm1b(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya)
decreased brown adipose tissue amount J:274297
decreased brown fat cell size J:274297
decreased subcutaneous adipose tissue amount J:274297
decreased white adipose tissue amount J:274297
Cnppd1tm1.1(KOMP)Vlcg/Cnppd1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cnppd1tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Cnr1tm1Lex/Cnr1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
decreased percent body fat/body weight J:185494
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6)
decreased total body fat amount J:93697
Cntnap5aem1(IMPC)J/Cntnap5aem1(IMPC)J
(C57BL/6NJ-Cntnap5aem1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Col1a1Aga2/Col1a1+
(involves: C3HeB/FeJ * C57BL/6J)
abnormal adipose tissue distribution J:129569
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ)
decreased percent body fat/body weight J:216423
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?

(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
increased white adipose tissue amount J:187378
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
decreased total body fat amount J:177113
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0

(involves: 129S4/SvJae * C57BL/6 * CD-1)
adipose tissue phenotype J:211215
decreased gonadal fat pad weight J:211215
Col1a2tm1b(EUCOMM)Wtsi/Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Col2a1M2J/Col2a1+
(B6;C3Fe-Col2a1M2J/GrsrJ)
decreased percent body fat/body weight J:187363
increased percent body fat/body weight J:187363
Col3a1Tsk2/Col3a1+
(C3H101H-Col3a1Tsk2/H)
adipose tissue inflammation J:31216
Col4a4em1(IMPC)H/Col4a4em1(IMPC)H
(C57BL/6N-Col4a4em1(IMPC)H/H)
decreased total body fat amount J:211773
Col4a5tm1b(EUCOMM)Wtsi/Y
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
decreased total body fat amount J:211773
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
decreased total body fat amount J:211773
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
decreased adipocyte glucose uptake J:171817
decreased subcutaneous adipose tissue amount J:171817
Colec10em2(IMPC)Tcp/Colec10em2(IMPC)Tcp
(C57BL/6NCrl-Colec10em2(IMPC)Tcp/Tcp)
decreased total body fat amount J:211773
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Copb2em1(IMPC)Bay/Copb2+
(C57BL/6N-Copb2em1(IMPC)Bay/Bay)
decreased total body fat amount J:211773
Coprstm1.1Efab/Coprstm1.1Efab
(Not Specified)
abnormal fat cell differentiation J:221154
abnormal white adipose tissue physiology J:221154
decreased retroperitoneal fat pad weight J:221154
decreased white fat cell number J:221154
increased white fat cell size J:221154
Coq2tm1b(EUCOMM)Hmgu/Coq2+
(C57BL/6N-Coq2tm1b(EUCOMM)Hmgu/H)
increased total body fat amount J:211773
Cox7a2lGt(OST241316)Lex/Cox7a2lGt(OST241316)Lex
(B6.129S5-Cox7a2lGt(OST241316)Lex)
whitened brown adipose tissue morphology J:215964
Cox7a2lGt(OST241316)Lex/Cox7a2lGt(OST241316)Lex
Tg(CAG-COX7A2L)#Sinos/0

(involves: 129S5/SvEvBrd * C57BL/6)
abnormal brown adipose tissue morphology J:215964
Cptm1b(KOMP)Wtsi/Cptm1b(KOMP)Wtsi
(B6N(Cg)-Cptm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Cpefat/Cpefat
(involves: HRS/J)
increased total body fat amount J:10872
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
abnormal percent body fat/body weight J:10872
Cpefat/Cpefat
Fina1C57BLKS/J/Fina1C57BLKS/J

(involves: C57BLKS/J * HRS/J)
increased total body fat amount J:100832
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
increased total body fat amount J:95741
Crbntm1b(KOMP)Wtsi/Crbntm1b(KOMP)Wtsi
(C57BL/6N-Crbntm1b(KOMP)Wtsi/Ucd)
decreased total body fat amount J:211773
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp)
decreased epididymal fat pad weight J:208570
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA)
decreased fat cell size J:75361
decreased percent body fat/body weight J:75361
decreased white adipose tissue amount J:75361
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J)
abnormal fat cell morphology J:208708
increased total body fat amount J:208708
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6)
abnormal adipose tissue physiology J:83683
abnormal white fat cell morphology J:83683
decreased brown fat cell size J:83683
decreased total body fat amount J:83683
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6)
increased white adipose tissue amount J:142448
Crtc2tm1a(EUCOMM)Wtsi/Crtc2tm1a(EUCOMM)Wtsi
(B6.B6N-Crtc2tm1a(EUCOMM)Wtsi)
increased adipocyte glucose uptake J:229999
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal brown fat cell morphology J:167211
abnormal white adipose tissue physiology J:167211
decreased brown fat cell lipid droplet size J:167211
decreased total body fat amount J:167211
decreased white fat cell size J:167211
increased brown fat cell number J:167211
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Asn/Cry2tm1Asn

(involves: 129P2/OlaHsd * C57BL/6)
abnormal brown adipose tissue morphology J:128437
decreased abdominal adipose tissue amount J:128437
decreased subcutaneous adipose tissue amount J:128437
decreased total body fat amount J:128437
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
abnormal abdominal fat pad morphology J:102499
increased abdominal adipose tissue amount J:102499
increased gonadal fat pad weight J:102499
increased mesenteric fat pad weight J:102499
increased subcutaneous adipose tissue amount J:102499
increased total body fat amount J:102499
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
abnormal mesenteric fat pad morphology J:142440
increased fat cell size J:142440
Csmd3em1(IMPC)Mbp/Csmd3em1(IMPC)Mbp
(C57BL/6NCrl-Csmd3em1(IMPC)Mbp/Mmucd)
decreased total body fat amount J:211773
Csnk1g3tm1a(EUCOMM)Wtsi/Csnk1g3tm1a(EUCOMM)Wtsi
(C57BL/6N-Csnk1g3tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ)
abnormal adipose tissue development J:184220
abnormal brown adipose tissue morphology J:184220
decreased white fat cell number J:184220
increased epididymal fat pad weight J:184220
increased gonadal fat pad weight J:184220
Cspg4tm1Ychan/Cspg4tm1Ychan
Olig2tm2(TVA,cre)Rth/Olig2+

(involves: 129 * C57BL/6N)
decreased epididymal fat pad weight J:184220
Ctdspl2tm2b(KOMP)Wtsi/Ctdspl2+
(C57BL/6N-Ctdspl2tm2b(KOMP)Wtsi/Bay)
decreased total body fat amount J:211773
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd)
increased fat cell size J:176727
increased total body fat amount J:176727
Cux1tm1Rhsc/Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J)
decreased total body fat amount J:100055
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA)
decreased white adipose tissue amount J:126841
increased fat cell size J:126841
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6)
adipose tissue phenotype J:217569
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Fabp4-cre)1Rev/0

(involves: 129P2/OlaHsd * C57BL/6)
increased brown adipose tissue mass J:217569
increased brown fat cell size J:217569
increased gonadal fat pad weight J:217569
increased mesenteric fat pad weight J:217569
increased retroperitoneal fat pad weight J:217569
increased subcutaneous adipose tissue amount J:217569
increased total body fat amount J:217569
increased white adipose tissue mass J:217569
increased white fat cell size J:217569
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
decreased total body fat amount J:91486
Cybatm1a(EUCOMM)Wtsi/Cybatm1a(EUCOMM)Wtsi
(C57BL/6N-Cybatm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Cybbtm1.1Abk/Cybbtm1.1Abk
Lyz2tm1(cre)Ifo/?

(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk)
decreased fat cell size J:245699
increased epididymal fat pad weight J:245699
Cybc1tm1a(KOMP)Wtsi/Cybc1tm1a(KOMP)Wtsi
(C57BL/6N-Cybc1tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:175295
Cyp4x1tm1.1Beld/Cyp4x1tm1.1Beld
(involves: C57BL/6)
increased abdominal adipose tissue amount J:254435
increased epididymal fat pad weight J:254435
increased white fat cell size J:254435
Cyp7b1tm1b(EUCOMM)Wtsi/Cyp7b1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7b1tm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J)
decreased total body fat amount J:147610
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju)
increased total body fat amount J:211773
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
increased total body fat amount J:211773
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
increased gonadal fat pad weight J:48086
increased mammary fat pad weight J:48086
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac)
increased fat cell size J:65805
increased gonadal fat pad weight J:65805
increased renal fat pad weight J:65805
increased total body fat amount J:65805
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv)
abnormal white adipose tissue morphology J:216958
increased abdominal adipose tissue amount J:216958
increased total body fat amount J:51076
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J)
increased abdominal fat pad weight J:79603, J:82070
increased gonadal fat pad weight J:82070
increased renal fat pad weight J:82070
Cyp20a1tm1a(EUCOMM)Wtsi/Cyp20a1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cyp20a1tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Cyp27b1tm1b(EUCOMM)Hmgu/Cyp27b1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp27b1tm1b(EUCOMM)Hmgu/Tcp)
decreased total body fat amount J:211773
Cystm1tm1b(EUCOMM)Hmgu/Cystm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cystm1tm1b(EUCOMM)Hmgu/Ieg)
increased total body fat amount J:211773
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi)
abnormal white adipose tissue physiology J:272118
decreased gonadal fat pad weight J:272118
decreased inguinal fat pad weight J:272118
Dach1tm1b(KOMP)Wtsi/Dach1+
(B6N(Cg)-Dach1tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Dact3tm1b(KOMP)Wtsi/Dact3tm1b(KOMP)Wtsi
(C57BL/6N-Dact3tm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dap3em1(IMPC)J/Dap3+
(C57BL/6NJ-Dap3em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Dbitm1Smdp/Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ)
abnormal white adipose tissue physiology J:204137
Dbitm2.1Smdp/Dbi+
Dbitm2.2Smdp/Dbi+
Tg(KRT14-cre)1Cgn/0

(involves: C57BL/6 * DBA/2 * FVB/N)
abnormal white adipose tissue physiology J:204137
Dbn1tm1a(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:175295
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ucd)
decreased total body fat amount J:211773
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Dbsq1C57BLKS/J/Dbsq1C3H/HeJ
Leprdb/Leprdb

(involves: C3H/HeJ * C57BLKS)
abnormal fat pad morphology J:116038
Dbsq1C57BLKS/J/Dbsq1C57BLKS/J
Leprdb/Leprdb

(involves: C3H/HeJ * C57BLKS)
abnormal fat pad morphology J:116038
Dbsty2NZO/HlLt/Dbsty2NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt)
increased white adipose tissue amount J:65256
Dbsty2NZO/HlLt/Dbsty2NZO/HlLt
(involves: NON/Lt * NZO/HlLt)
increased white adipose tissue amount J:65256
Dbx1tm2Jcor/Dbx1tm1Tmj
Tg(Nkx2-1-cre)2Sand/0

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased percent body fat/body weight J:221571
Dclk1tm1a(EUCOMM)Wtsi/Dclk1+
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
adipose tissue inflammation J:214136
increased total body fat amount J:214136
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng)
decreased percent body fat/body weight J:134371
Del(7Coro1a-Spn)1Dolm/+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6N * CD-1)
abnormal abdominal fat pad morphology J:210018
Del(8Npy5r-Npy1r)1Snby/Del(8Npy5r-Npy1r)1Snby
(involves: 129 * C57BL/6)
increased gonadal fat pad weight J:225097
increased inguinal fat pad weight J:225097
increased mesenteric fat pad weight J:225097
increased retroperitoneal fat pad weight J:225097
increased total body fat amount J:225097
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae)
decreased percent body fat/body weight J:72926
Del(11Cops3-Rnf112)1Jrl/+
(involves: 129S7/SvEvBrd * C57BL/6)
increased abdominal fat pad weight J:83302
increased percent body fat/body weight J:83302
Del(16Lipi-Usp25)1Dja/+
(involves: 129P2/OlaHsd * C57BL/6)
increased percent body fat/body weight J:184302
increased subcutaneous adipose tissue amount J:184302
increased total body fat amount J:184302
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA)
decreased body fat mass J:276600
Dfb/Dfb+
(BALB/cByJ-Dfb/J)
decreased percent body fat/body weight J:110189
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
decreased percent body fat/body weight J:111346
Dgat1tm1Far/Dgat1tm1Far
(B6J.129S4-Dgat1tm1Far)
decreased mammary fat pad weight J:128259
Dgat2tm1Lex/Dgat2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
decreased subcutaneous adipose tissue amount J:103485
Dhcr24tm1Lex/Dhcr24tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
abnormal mesenteric fat pad morphology J:87402
decreased subcutaneous adipose tissue amount J:87402
Dhx29tm1.1(KOMP)Vlcg/Dhx29+
(C57BL/6N-Dhx29tm1.1(KOMP)Vlcg/J)
increased total body fat amount J:211773
Dio2tm1Acb/Dio2tm1Acb
Tg(Cga-cre)3Sac/0

(involves: C57BL/6J * SJL)
decreased total body fat amount J:197623
Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
increased total body fat amount J:81054
Dlg3tm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Dlg3tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dlg4tm1e(EUCOMM)Wtsi/Dlg4tm1e(EUCOMM)Wtsi
(C57BL/6N-Dlg4tm1e(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dlk1tm1.1Jvs/Dlk1+
Myf5tm3(cre)Sor/Myf5+

(involves: 129P2 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
decreased brown adipose tissue mass J:167124
Dlk1tm1.2Jvs/Dlk1+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
decreased fat cell size J:194130
Dlk1tm1Hsul/Dlk1+
(involves: 129 * C57BL/6J)
abnormal fat pad morphology J:77909
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J))
abnormal fat pad morphology J:77909
increased fat cell size J:77909
Dll1m1Mhda/Dll1+
(C3HeB/FeJ-Dll1m1Mhda)
decreased total body fat amount J:150183
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos)
decreased total body fat amount J:150183
Dmbx1tm1Sse/Dmbx1tm1Sse
(involves: ICR)
abnormal fat cell morphology J:125193
Dmdmdx-5Cv/Y
(B6Ros.Cg-Dmdmdx-5Cv)
decreased body fat mass J:177391
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx)
decreased body fat mass J:177391
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx)
adipose tissue phenotype J:160773
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx)
increased total body fat amount J:160773
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH)
increased total body fat amount J:211773
Dnajb2em1(IMPC)J/Dnajb2em1(IMPC)J
(C57BL/6NJ-Dnajb2em1(IMPC)J/J)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh)
decreased percent body fat/body weight J:98194
Dnajc7tm1b(KOMP)Wtsi/Dnajc7tm1b(KOMP)Wtsi
(C57BL/6N-Dnajc7tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
decreased white adipose tissue amount J:204025
Dnase1l2tm1(KOMP)Wtsi/Dnase1l2tm1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Ucd)
decreased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/H)
decreased total body fat amount J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Dnd1em1(IMPC)Bay/Dnd1em1(IMPC)Bay
(C57BL/6N-Dnd1em1(IMPC)Bay/Bay)
increased total body fat amount J:211773
Dnm3ostm1Tkk/Dnm3ostm1Tkk
(involves: 129 * C57BL/6 * ICR)
abnormal epididymal fat pad morphology J:143209
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J)
increased total body fat amount J:211773
Dob1AKR/J/Dob1AKR/J
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:20129
Dob1AKR/J/Dob1SWR/J
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:20129
Dob2AKR/J/Dob2SWR/J
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:20700
Dob2SWR/J/Dob2SWR/J
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:20700
Dob3AKR/J/Dob3AKR/J
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:20700
Dob3AKR/J/Dob3SWR/J
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:20700
Dob7SWR/J/?
(involves: AKR/J * SWR/J)
increased white adipose tissue amount J:43487
Dock7m/Dock7m
(B6.D(Cg)-Dock7m)
abnormal brown adipose tissue mass J:45425
decreased white adipose tissue amount J:48831
Dok1tm1Yyam/Dok1tm1Yyam
(B6.129S4-Dok1tm1Yyam)
decreased brown adipose tissue mass J:133566
decreased epididymal fat pad weight J:133566
decreased fat cell size J:133566
decreased inguinal fat pad weight J:133566
decreased percent body fat/body weight J:133566
Dok1tm1Yyam/Dok1tm1Yyam
Ppargtm1Laz/Ppargtm1Laz

(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
abnormal fat cell morphology J:133566
adipose tissue phenotype J:133566
Dok7tm1.1(KOMP)Vlcg/Dok7+
(C57BL/6N-Dok7tm1.1(KOMP)Vlcg/Ucd)
increased total body fat amount J:211773
Dp(11Cops3-Rnf112)1Jrl/0
(involves: 129S7/SvEvBrd * C57BL/6)
decreased abdominal fat pad weight J:83302
decreased percent body fat/body weight J:83302
Dp(11Cops3-Rnf112)1Jrl/0
Tyrc-Brd/Tyrc-Brd

(B6Brd.Cg-Tyrc-Brd Dp(11Cops3-Rnf112)1Jrl)
decreased abdominal fat pad weight J:138598
Dpttm1Hsh/Dpttm1Hsh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased total body fat amount J:78845
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J)
decreased inguinal fat pad weight J:106832
Drd3tm1Stl/Drd3tm1Stl
(involves: 129S2/SvPas * C57BL/6)
increased percent body fat/body weight J:89345
increased total body fat amount J:89345
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
decreased body fat mass J:138683
Dsg1btm1a(KOMP)Wtsi/Dsg1btm1a(KOMP)Wtsi
(C57BL/6N-Dsg1btm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
decreased subcutaneous adipose tissue amount J:219200
decreased total body fat amount J:219200
Dsg3tm1Stan/Dsg3tm1Stan
(involves: 129X1/SvJ * C57BL/6J)
decreased total body fat amount J:40804
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ)
decreased abdominal adipose tissue amount J:83117
decreased subcutaneous adipose tissue amount J:83117
Duox2thyd/Duox2thyd
(B6(129)-Duox2thyd/J)
decreased percent body fat/body weight J:121821
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Dusp1tm1(KOMP)Wtsi/Dusp1tm1(KOMP)Wtsi
(C57BL/6N-Dusp1tm1(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:175295
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
decreased abdominal fat pad weight J:129718
decreased epididymal fat pad weight J:129718
decreased fat cell size J:129718
decreased total body fat amount J:129718
Dync1i2tm1a(EUCOMM)Wtsi/Dync1i2+
(C57BL/6N-Dync1i2tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
E2f1tm1Meg/E2f1tm1Meg
E2f3tm2.1Gle/E2f3tm2.1Gle

(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss)
adipose tissue phenotype J:138289
decreased white adipose tissue amount J:138289
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
abnormal fat cell differentiation J:89720
decreased total body fat amount J:89720
increased adipocyte glucose uptake J:89720
E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
decreased white adipose tissue amount J:138289
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:147179
Ebf2tm1.1Ggc/Ebf2tm1.1Ggc
(involves: 129S2/SvPas * C57BL/6J)
abnormal fat cell morphology J:104946
Ecscrtm1a(KOMP)Wtsi/Ecscrtm1a(KOMP)Wtsi
(involves: C57BL/6N)
abnormal white adipose tissue physiology J:236657
Edartm1.1Bamo/Edartm1.1Bamo
(involves: 129S4/SvJae * FVB)
abnormal mammary fat pad morphology J:193816
Edn2tm1.1Nat/Edn2tm1.1Nat
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
decreased total body fat amount J:201436
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac)
abnormal brown adipose tissue morphology J:201436
Eef1b2em1(IMPC)J/Eef1b2em1(IMPC)J
(C57BL/6NJ-Eef1b2em1(IMPC)J/Mmjax)
decreased total body fat amount J:211773
Efemp1tm2Lmar/Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:132043
decreased total body fat amount J:132043
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd)
decreased total body fat amount J:211773
Egfrwa2/Egfrwa2
Ptpn11tm1Paw/Ptpn11+

(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6)
decreased subcutaneous adipose tissue amount J:75413
Ehd2tm1.1Cbm/Ehd2tm1.1Cbm
(B6N.129(Cg)-Ehd2tm1.1Cbm)
abnormal adipose tissue physiology J:285350
abnormal beige fat cell morphology J:285350
abnormal white fat cell morphology J:285350
increased adipocyte glucose uptake J:285350
increased brown fat cell lipid droplet size J:285350
increased gonadal fat pad weight J:285350
increased inguinal fat pad weight J:285350
increased white fat cell lipid droplet size J:285350
increased white fat cell size J:285350
Ehd2tm1Cbm/Ehd2tm1Cbm
(involves: 129S1/Sv * 129X1/SvJ)
increased white fat cell lipid droplet size J:285350
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Myf5tm3(cre)Sor/Myf5+

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
decreased brown fat cell size J:207678
decreased brown fat lipid droplet number J:207678
decreased interscapular fat pad weight J:207678
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0

(involves: 129P2/OlaHsd * FVB/NJ)
abnormal brown adipose tissue physiology J:207678
increased brown fat cell lipid droplet size J:207678
increased epididymal fat pad weight J:207678
increased interscapular fat pad weight J:207678
increased white fat cell lipid droplet size J:207678
Ehmt1tm1b(EUCOMM)Hmgu/Ehmt1+
(C57BL/6N-Ehmt1tm1b(EUCOMM)Hmgu/Nju)
decreased total body fat amount J:211773
Eif2b5tm1Itl/Eif2b5tm1Itl
(involves: 129S/SvEv * C57BL * Swiss Webster)
decreased percent body fat/body weight J:179801
Eif3mtm1.1Nju/Eif3m+
(involves: 129 * FVB/N)
adipose tissue phenotype J:204915
decreased total fat pad weight J:204915
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * BALB/c)
abnormal white adipose tissue physiology J:72217
decreased gonadal fat pad weight J:72217
decreased inguinal fat pad weight J:72217
decreased retroperitoneal fat pad weight J:72217
decreased total body fat amount J:72217
decreased white adipose tissue amount J:72217
Eif4hGt(Ex279)Byg/Eif4hGt(Ex279)Byg
(involves: 129P2/OlaHsd * C57BL/6)
decreased inguinal fat pad weight J:181945
decreased total body fat amount J:181945
Eif6tm1Sbif/Eif6+
(involves: 129 * C57BL/6)
abnormal fat cell morphology J:141257
decreased total body fat amount J:141257
Elfn1tm1.1(KOMP)Vlcg/Elfn1tm1.1(KOMP)Vlcg
(C57BL/6N-Elfn1tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Elmod1tm1b(EUCOMM)Hmgu/Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H)
decreased total body fat amount J:211773
Elmod2tm1b(EUCOMM)Hmgu/Elmod2+
(C57BL/6N-Elmod2tm1b(EUCOMM)Hmgu/H)
increased total body fat amount J:211773
Elof1tm1.1(KOMP)Vlcg/Elof1+
(C57BL/6N-Elof1tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Elp1tm1Id/Elp1tm1.1Id
Tg(Hsp70-1-cre)6Arge/0

(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
decreased total body fat amount J:188923
Elp1tm1Id/Elp1tm1.1Id
Tg(IKBKAP*)#Sasl/0

(involves: 129S1/Sv * C57BL/6N)
decreased epididymal fat pad weight J:229459
decreased total body fat amount J:229459
Elp1tm1Id/Elp1tm1Id
Tg(Hsp70-1-cre)6Arge/0

(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
decreased total body fat amount J:188923
Emc8tm1b(EUCOMM)Hmgu/Emc8+
(C57BL/6N-Emc8tm1b(EUCOMM)Hmgu/H)
increased total body fat amount J:211773
Eml1em1(IMPC)Wtsi/Eml1em1(IMPC)Wtsi
(C57BL/6N-Eml1em1(IMPC)Wtsi/Wtsi)
decreased total body fat amount J:211773
Emx1tm1.1(KOMP)Vlcg/Emx1tm1.1(KOMP)Vlcg
(C57BL/6N-Emx1tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
EnamAbte2/Enam+
(C3HeB/FeJ-EnamAbte2)
decreased total body fat amount J:220423
Enamabte/Enam+
(C3HeB/FeJ-Enamabte)
decreased total body fat amount J:220423
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Endoutm1(KOMP)Vlcg/Endoutm1(KOMP)Vlcg
(C57BL/6N-Endoutm1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl)
increased percent body fat/body weight J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
increased body fat mass J:225402
increased percent body fat/body weight J:225402
Enhotm1Cmwo/Enhotm1Cmwo
(B6.129S1-Enhotm1Cmwo)
adipose tissue phenotype J:216870
Enox1tm1.1(KOMP)Vlcg/Enox1+
(C57BL/6N-Enox1tm1.1(KOMP)Vlcg/J)
increased total body fat amount J:211773
Enpp1tm1Gdg/Enpp1tm1Gdg
(involves: 129S1/Sv)
abnormal adipose tissue morphology J:133011
Entpd6tm1a(KOMP)Wtsi/Entpd6tm1a(KOMP)Wtsi
(C57BL/6N-Entpd6tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Eomestm1b(EUCOMM)Wtsi/Eomes+
(C57BL/6N-Eomestm1b(EUCOMM)Wtsi/H)
increased total body fat amount J:211773
Epfpq1L6/Epfpq1L6
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfpq1L6/Epfpq1M16i
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfpq2L6/Epfpq2L6
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfpq3L6/Epfpq3L6
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfpq4L6/Epfpq4L6
(involves: L6 * M16i)
abnormal fat pad morphology J:88793
Epfq1L6/Epfq1L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq1L6/Epfq1M16i
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq2L6/Epfq2L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq2L6/Epfq2M16i
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq3L6/Epfq3L6
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfq4L6/Epfq4L6
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfq5L6/Epfq5L6
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epfq5L6/Epfq5M16i
(involves: L6 * M16i)
abnormal fat pad morphology J:87793
Epg5tm1Ygz/Epg5tm1Ygz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
decreased white adipose tissue amount J:196603
decreased white fat cell lipid droplet size J:196603
decreased white fat cell size J:196603
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
increased body fat mass J:173769
Eprstm1.1Xen/Eprstm1.1Xen
(C57BL/6-Eprstm1.1Xen)
abnormal adipose tissue physiology J:244749
decreased abdominal adipose tissue amount J:244749
decreased brown adipose tissue amount J:244749
decreased white fat cell size J:244749
Eprstm2.1Xen/Eprstm2.1Xen
Rps6kb1tm1Nte/Rps6kb1tm1Nte

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased epididymal fat pad weight J:244749
decreased inguinal fat pad weight J:244749
decreased interscapular fat pad weight J:244749
decreased mesenteric fat pad weight J:244749
decreased retroperitoneal fat pad weight J:244749
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:41161
Ercc2tm1Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
decreased total body fat amount J:48256
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
abnormal fat cell morphology J:48256
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
Xpatm1Hvs/Xpatm1Hvs

(involves: 129P2/OlaHsd * C57BL/6)
abnormal adipose tissue distribution J:76608
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs

(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
abnormal abdominal fat pad morphology J:122013
lipodystrophy J:122013
Esco1tm1(KOMP)Wtsi/Esco1tm1(KOMP)Wtsi
(C57BL/6N-Esco1tm1(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:175295
Esr1tm1Geog/Esr1tm1Geog
(involves: 129X1/SvJ * C57BL/6)
increased gonadal fat pad weight J:135981
increased mammary fat pad weight J:135981
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
increased gonadal fat pad weight J:66077
increased retroperitoneal fat pad weight J:66077
increased total body fat amount J:66077
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Esr1tm1Ksk)
adipose tissue phenotype J:65806
increased epididymal fat pad weight J:65806
increased inguinal fat pad weight J:65806
increased parametrial fat pad weight J:65806
increased renal fat pad weight J:65806
increased white adipose tissue amount J:65806
increased white fat cell number J:65806
increased white fat cell size J:65806
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc

(involves: 129P2/OlaHsd * C57BL/6J)
increased gonadal fat pad weight J:66077
increased retroperitoneal fat pad weight J:66077
increased total body fat amount J:66077
Esr1tm1Syeh/Esr1tm1Syeh
Tmem163Tg(ACTB-cre)2Mrt/0

(involves: 129X1/SvJ * FVB/N)
increased total body fat amount J:147191
Esr1tm4.2Ksk/Esr1tm4.2Ksk
(involves: C57BL/6 * C57BL/6NTac * CBA)
increased total body fat amount J:191182
Esr1tm4.2Ksk/Esr1tm4.2Ksk
Mir22tm1Boet/Mir22tm1Boet
Tg(Ckmm-cre)5Khn/0

(involves: 129S2/SvPas * C57BL/6 * FVB)
adipose tissue phenotype J:266382
Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas)
increased total body fat amount J:123373
Esrratm1.1(KOMP)Vlcg/Esrratm1.1(KOMP)Vlcg
(C57BL/6N-Esrratm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Esrratm1Vgi/Esrratm1Vgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal adipose tissue physiology J:86433
decreased epididymal fat pad weight J:86433
decreased inguinal fat pad weight J:86433
decreased percent body fat/body weight J:86433
decreased retroperitoneal fat pad weight J:86433
decreased white fat cell size J:86433
increased brown fat cell lipid droplet size J:119525
Esyt3tm1b(EUCOMM)Wtsi/Esyt3tm1b(EUCOMM)Wtsi
(C57BL/6N-Esyt3tm1b(EUCOMM)Wtsi/H)
decreased total body fat amount J:211773
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
absent subcutaneous adipose tissue J:122058
Eya1tm1b(EUCOMM)Hmgu/Eya1+
(C57BL/6N-Eya1tm1b(EUCOMM)Hmgu/Bay)
decreased total body fat amount J:211773
F7tm1b(EUCOMM)Hmgu/F7+
(C57BL/6N-F7tm1b(EUCOMM)Hmgu/H)
increased total body fat amount J:211773
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto)
decreased uterine fat pad weight J:64975
increased epididymal fat pad weight J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal brown adipose tissue morphology J:167535
abnormal brown adipose tissue physiology J:167535
decreased brown adipose tissue amount J:167535
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota

(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
abnormal brown adipose tissue morphology J:217245
abnormal brown adipose tissue thermogenesis J:217245
decreased brown adipose tissue mass J:217245
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob

(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
increased adipocyte glucose uptake J:111878
increased white adipose tissue amount J:111878
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota)
decreased subcutaneous adipose tissue amount J:81609
increased adipocyte glucose uptake J:81609
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi)
abnormal white adipose tissue physiology J:258290
adipose tissue inflammation J:258290
adipose tissue phenotype J:258290
decreased white fat cell size J:258290
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Fancltm1b(EUCOMM)Hmgu/Fancltm1b(EUCOMM)Hmgu
(C57BL/6N-Fancltm1b(EUCOMM)Hmgu/Nju)
increased total body fat amount J:211773
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?

(involves: 129X1/SvJ * C57BL/6 * DBA)
decreased total body fat amount J:127793
decreased total fat pad weight J:127793
Fasntm1Sem/Fasntm1Sem
Tg(Ins2-cre)25Mgn/?

(involves: 129X1/SvJ * C57BL/6 * DBA)
decreased total body fat amount J:127482
Fatmq1C57BL/6J/Fatmq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
decreased total body fat amount J:117545
Fatmq1CAST/EiJ/Fatmq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
decreased total body fat amount J:117545
Fatmq2C57BL/6J/Fatmq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
decreased total body fat amount J:117545
Fatmq2CAST/EiJ/Fatmq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
decreased total body fat amount J:117545
Fatpad3CAST/EiJ/?
(involves: CAST/EiJ * M16i)
abnormal fat pad morphology J:108423
increased gonadal fat pad weight J:108423
Fatq1MH/?
(involves: C57BL/6J * MH)
increased white adipose tissue amount J:55483
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi)
increased total body fat amount J:211773
Fbn1em1Chop/Fbn1+
(C57BL/6-Fbn1em1Chop)
decreased body fat mass J:251851
Fbn1tm2.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
decreased subcutaneous adipose tissue amount J:206074
Fbn1tm3.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
decreased subcutaneous adipose tissue amount J:206074
Fbn1tm3.2Lysa/Fbn1+
(Not Specified)
decreased subcutaneous adipose tissue amount J:181493
Fbn1tm3.2Lysa/Fbn1tm3.2Lysa
(Not Specified)
decreased subcutaneous adipose tissue amount J:181493
Fcortm1Jnak/Fcortm1Jnak
(involves: C57BL/6NCrlj * CBA/JNCrlj)
increased white fat cell size J:184684
Fcrlstm1Lex/Fcrlstm1Lex
(B6;129S5-Fcrlstm1Lex/Mmucd)
increased total body fat amount J:171883
Fechm1Pas/Fechm1Pas
(involves: 129/Sv * BALB/c)
decreased total body fat amount J:2021
Fen1tm2Klng/Fen1tm2Klng
(involves: 129X1/SvJ * C57BL/6)
increased fat cell size J:138901
increased white adipose tissue amount J:138901
Ffar3tm1Dgen/Ffar3tm1Dgen
(B6.129P2-Ffar3tm1Dgen)
abnormal adipose tissue physiology J:160365
Ffar3tm1Reh/Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J)
decreased epididymal fat pad weight J:143567
Ffar4tm1(KOMP)Vlcg/Ffar4tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
abnormal beige fat cell physiology J:240649
abnormal brown adipose tissue physiology J:240649
abnormal brown fat cell differentiation J:240649
abnormal white adipose tissue morphology J:240649
abnormal white adipose tissue physiology J:240649
abnormal white fat cell differentation J:240649
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
increased total body fat amount J:182599
increased white adipose tissue amount J:182599
increased white fat cell size J:182599
Fgf10tm1b(EUCOMM)Wtsi/Fgf10+
(C57BL/6N-Fgf10tm1b(EUCOMM)Wtsi/H)
increased total body fat amount J:211773
Fgf10tm1Ska/Fgf10tm1Ska
(involves: C57BL/6 * CBA)
abnormal adipose tissue morphology J:108349
abnormal mammary fat pad morphology J:73434
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf)
abnormal adipose tissue morphology J:157309
abnormal brown fat cell morphology J:157309
increased brown adipose tissue amount J:157309
increased gonadal fat pad weight J:157309
increased total body fat amount J:157309
increased white fat cell size J:157309
Fgf21tm1Lex/Fgf21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
abnormal brown adipose tissue physiology J:240649
abnormal brown adipose tissue thermogenesis J:240649
abnormal white adipose tissue physiology J:240649
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit)
abnormal white fat cell size J:157334
decreased white adipose tissue amount J:157334
decreased white fat cell size J:157334
increased white adipose tissue amount J:157334
increased white fat cell size J:157334
Fgfr2tm1Dsn/Fgfr2tm1Dsn
Tg(KRT5-cre)5132Jlj/0

(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
adipose tissue inflammation J:119723
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
abnormal brown fat cell morphology J:199844
decreased white fat cell number J:199844
increased brown fat cell lipid droplet size J:199844
increased white adipose tissue amount J:199844
increased white fat cell size J:199844
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Lepob/Lepob
Tg(Fabp4-cre)1Rev/?

(involves: 129S6/SvEvTac * C57BL/6J)
decreased subcutaneous adipose tissue amount J:212437
decreased white adipose tissue amount J:212437
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?

(involves: 129S6/SvEvTac * C57BL/6J)
abnormal brown fat cell morphology J:212437
abnormal white adipose tissue morphology J:212437
abnormal white adipose tissue physiology J:212437
abnormal white fat cell morphology J:212437
decreased brown fat lipid droplet number J:212437
increased brown fat cell lipid droplet size J:212437
Flt4Chy/Flt4+
(involves: C3H)
abnormal adipose tissue distribution J:72387
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe)
abnormal fat pad morphology J:223365
abnormal inguinal fat pad morphology J:223365
decreased abdominal adipose tissue amount J:223365
decreased epididymal fat pad weight J:223365
decreased subcutaneous adipose tissue amount J:223365
decreased white fat cell size J:223365
Fndc9tm1.1(KOMP)Vlcg/Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd)
increased total body fat amount J:211773
Fob1F line/Fob1F line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fob1F line/Fob1L line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fob2F line/Fob2F line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fob3F line/Fob3F line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fob3F line/Fob3L line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fob3aL line/Fob3aL line
(F.L-Fob3a)
decreased total body fat amount J:90000
Fob3bL line/Fob3bL line
(F.L-Fob3b)
decreased total body fat amount J:90000
Fob4F line/Fob4F line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fob4F line/Fob4L line
(involves: F line * L line)
increased white adipose tissue amount J:59227
Fosem1(IMPC)Mbp/Fos+
(C57BL/6N-Fosem1(IMPC)Mbp/Ucd)
increased total body fat amount J:211773
Fosl2tm2Wag/Fosl2tm2Wag
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0

(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
adipose tissue phenotype J:211215
increased gonadal fat pad weight J:211215
Foxa2tm1.1Stf/Foxa2tm1.1Stf
Tg(Nes-cre)1Kln/0

(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln)
decreased total body fat amount J:155391
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk)
abnormal beige fat cell morphology J:216477
decreased body fat mass J:216477
decreased brown fat cell size J:216477
decreased white fat cell size J:216477
increased adipocyte glucose uptake J:216477
Foxc2tm1Miu/Foxc2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
increased brown adipose tissue amount J:83436
Foxj3tm1b(EUCOMM)Wtsi/Foxj3+
(C57BL/6N-Foxj3tm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified)
abnormal adipose tissue physiology J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac)
increased percent body fat/body weight J:179687
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
decreased white fat cell size J:236585
Foxp1tm1b(KOMP)Wtsi/Foxp1+
(C57BL/6N-Foxp1tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Foxp2tm2.2Woen/Foxp2+
(involves: C57BL/6 * C57BL/6J)
decreased total fat pad weight J:150425
Fshrtm1Saco/Fshrtm1Saco
(involves: 129)
abnormal abdominal fat pad morphology J:65577
increased total fat pad weight J:65577
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
abnormal abdominal fat pad morphology J:119526
abnormal adipose tissue distribution J:119526
Ftms1SJL/J/Ftms1SJL/J
(involves: MRL/MpJ * SJL/J)
increased total body fat amount J:106033
FtoI367F/Fto+
(involves: C3H/HeH * C57BL/6J)
decreased percent body fat/body weight J:152163
decreased total body fat amount J:152163
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J)
decreased percent body fat/body weight J:152163
decreased total body fat amount J:152163
Ftotm1.1Rdc/Ftotm1.1Rdc
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
increased total body fat amount J:194922
Ftotm1.2Pzg/Ftotm1.2Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
increased total body fat amount J:166984
Ftotm1.3Pzg/Ftotm1.3Pzg
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
increased total body fat amount J:166984
Ftotm1Urt/Ftotm1Urt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased gonadal fat pad weight J:147471
decreased total body fat amount J:147471
decreased white fat cell size J:147471
Ftotm1Urt/Ftotm1Urt
Lepob/Lepob

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal adipose tissue morphology J:219118
increased fat cell size J:219118
increased gonadal fat pad weight J:219118
increased inguinal fat pad weight J:219118
increased interscapular fat pad weight J:219118
increased percent body fat/body weight J:219118
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
abnormal fat cell differentiation J:232077
abnormal white adipose tissue physiology J:209000
decreased brown adipose tissue amount J:209000
decreased epididymal fat pad weight J:232077
decreased gonadal fat pad weight J:209000, J:225236
decreased inguinal fat pad weight J:209000
decreased omental fat pad weight J:209000
decreased renal fat pad weight J:209000
decreased total body fat amount J:232077
decreased white fat cell size J:232077
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd)
abnormal brown adipose tissue thermogenesis J:219653
abnormal white adipose tissue physiology J:219653
decreased abdominal adipose tissue amount J:219653
decreased body fat mass J:219653
decreased total fat pad weight J:219653
decreased white adipose tissue mass J:219653
decreased white fat cell size J:219653
G2e3em1(IMPC)Tcp/G2e3em1(IMPC)Tcp
(C57BL/6NCrl-G2e3em1(IMPC)Tcp/Tcp)
increased total body fat amount J:211773
Gabbr1tm1Dgen/Gabbr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
absent subcutaneous adipose tissue J:101679
Gabrg3em1(IMPC)J/Gabrg3em1(IMPC)J
(C57BL/6NJ-Gabrg3em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv)
abnormal brown adipose tissue physiology J:213702
Galnt12em1(IMPC)J/Galnt12em1(IMPC)J
(C57BL/6NJ-Galnt12em1(IMPC)J/J)
decreased total body fat amount J:211773
Galnt18tm1b(KOMP)Wtsi/Galnt18tm1b(KOMP)Wtsi
(C57BL/6N-Galnt18tm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Gamttm1Isb/Gamttm1Isb
(involves: 129S1/Sv * 129X1/SvJ)
decreased total body fat amount J:90367
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Gas7em1(IMPC)J/Gas7em1(IMPC)J
(C57BL/6NJ-Gas7em1(IMPC)J/J)
increased total body fat amount J:211773
Gata3tm3Gsv/Gata3tm3Gsv
Tg(KRT14-cre)8Brn/0

(involves: 129P2/OlaHsd * FVB/N)
absent subcutaneous adipose tissue J:117058
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
decreased subcutaneous adipose tissue amount J:191142
decreased total body fat amount J:191142
decreased white adipose tissue amount J:191142
increased adipocyte glucose uptake J:191142
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
decreased abdominal adipose tissue amount J:176507
decreased subcutaneous adipose tissue amount J:176507
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL)
decreased brown adipose tissue amount J:81772
decreased gonadal fat pad weight J:81772
decreased interscapular fat pad weight J:81772
decreased total body fat amount J:81772
Gdap2em1(IMPC)Wtsi/Gdap2em1(IMPC)Wtsi
(C57BL/6N-Gdap2em1(IMPC)Wtsi/WtsiIeg)
decreased total body fat amount J:211773
Gdf3tm1Zuk/Gdf3tm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6J)
abnormal fat cell morphology J:143083
decreased white adipose tissue amount J:143083
Gdf15tm1Breit/Gdf15tm1Breit
(B6.Cg-Gdf15tm1Breit)
increased inguinal fat pad weight J:197174
increased mesenteric fat pad weight J:197174
increased retroperitoneal fat pad weight J:197174
increased total body fat amount J:197174
increased white adipose tissue amount J:197174
Gfpq1CAST/EiJ/Gfpq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
increased gonadal fat pad weight J:117545
Gfpt2tm1b(EUCOMM)Wtsi/Gfpt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gfpt2tm1b(EUCOMM)Wtsi/Ieg)
decreased total body fat amount J:211773
Gfra2tm1Msa/Gfra2tm1Msa
(either: B6.129-Gfra2tm1Msa or 129S2.129-Gfra2tm1Msa)
decreased gonadal fat pad weight J:93911
Ggcxtm1.1Kry/Ggcxtm1.1Kry
Tg(Col1a1-cre)1Kry/0

(involves: FVB/N)
decreased epididymal fat pad weight J:264734
GhSma1/Gh+
(C3HeB/FeJ-GhSma1)
increased white adipose tissue amount J:89518
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1)
increased brown adipose tissue amount J:89518
increased white adipose tissue amount J:89518
Ghrtm1.1Jero/Ghrtm1.1Jero
(B6.129X1-Ghrtm1.1Jero)
decreased epididymal fat pad weight J:155335
decreased inguinal fat pad weight J:155335
increased percent body fat/body weight J:155335
Ghrtm1c(KOMP)Wtsi/Ghrtm1c(KOMP)Wtsi
Tg(Fabp4-cre)1Rev/0

(involves: C57BL/6N)
increased brown adipose tissue amount J:206358
increased gonadal fat pad weight J:206358
increased mesenteric fat pad weight J:206358
increased retroperitoneal fat pad weight J:206358
increased subcutaneous adipose tissue amount J:206358
increased total body fat amount J:206358
increased white fat cell size J:206358
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd)
decreased epididymal fat pad weight J:95149
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c)
increased interscapular fat pad weight J:105686
increased percent body fat/body weight J:132437, J:105686
increased retroperitoneal fat pad weight J:132437, J:105686
increased white adipose tissue amount J:132437
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
increased abdominal fat pad weight J:107763
Ghrtm2Mwat/Ghrtm2Mwat
(involves: 129X1/SvJ * C57BL)
increased total body fat amount J:95149
Ghrhtm1b(EUCOMM)Wtsi/Ghrhtm1b(EUCOMM)Wtsi
(C57BL/6N-Ghrhtm1b(EUCOMM)Wtsi/Tcp)
increased total body fat amount J:211773
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit)
increased total body fat amount J:3735
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit/J)
increased total body fat amount J:95779
Ghrhrlit/Ghrhrlit
Prlrtm1Cnp/Prlrtm1Cnp

(involves: 129P2/OlaHsd * C57BL/6J)
increased total body fat amount J:95779
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J)
increased total body fat amount J:211773
Ghrltm1Mws/Ghrltm1Mws
(involves: C57BL/6)
abnormal adipose tissue amount J:90698
Ghsrtm1Lowl/Ghsrtm1Lowl
(involves: C57BL/6J)
decreased total body fat amount J:104704
Gimap6tm1b(KOMP)Wtsi/Gimap6tm1b(KOMP)Wtsi
(C57BL/6N-Gimap6tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Gjd4tm1.1(KOMP)Vlcg/Gjd4tm1.1(KOMP)Vlcg
(C57BL/6N-Gjd4tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Gk5m1Btlr/Gk5m1Btlr
(C57BL/6J-Gk5m1Btlr)
decreased white fat cell number J:243852
Gkn1tm1.1(KOMP)Vlcg/Gkn1tm1.1(KOMP)Vlcg
(C57BL/6N-Gkn1tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Glp1rtm1Ddr/Glp1rtm1Ddr
(involves: 129S1/Sv * 129X1/SvJ)
decreased total body fat amount J:206563
Glp2rtm1.1Xfg/Glp2rtm1.1Xfg
Tg(Pomc1-cre)16Lowl/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
increased percent body fat/body weight J:189593
Glra1nmf11/Glra1nmf11
(C57BL/6J-Glra1nmf11/J)
decreased white adipose tissue amount J:78134
Gm94tm1b(KOMP)Wtsi/Gm94+
(C57BL/6N-Gm94tm1b(KOMP)Wtsi/J)
increased total body fat amount J:211773
GnasOedsml/Gnas+
(involves: 101/H * C3H/HeH)
increased brown adipose tissue amount J:65007
Gnastm1Kel/Gnas+
(involves: 129S2/SvPas * C57BL/6J)
decreased brown adipose tissue amount J:91703
decreased interscapular fat pad weight J:91703
decreased white adipose tissue amount J:91703
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1)
abnormal brown adipose tissue morphology J:60971
decreased brown adipose tissue amount J:60971
decreased epididymal fat pad weight J:60971
decreased interscapular fat pad weight J:60971
decreased white adipose tissue amount J:60971
increased brown adipose tissue amount J:60971
increased brown fat cell lipid droplet size J:60971
increased interscapular fat pad weight J:60971
increased white adipose tissue amount J:60971
Gnastm2Jop/Gnas+
(involves: 129S/SvEv)
decreased percent body fat/body weight J:182868
decreased total body fat amount J:182868
Gnastm3Jop/Gnas+
(involves: 129S/SvEv)
decreased total body fat amount J:182868
Gnastm3Kel/Gnas+
(involves: 129P2/OlaHsd * C57BL/6J * DS/2)
abnormal fat pad morphology J:143477
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss * CD-1)
abnormal adipose tissue morphology J:99237
increased brown adipose tissue amount J:99237
increased interscapular fat pad weight J:99237
increased total body fat amount J:99237
increased white adipose tissue amount J:99237
Gnastm5Lsw/Gnastm5Lsw
Tg(Alb1-cre)1Dlr/?

(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
decreased total body fat amount J:102504
Gnastm5Lsw/Gnastm5Lsw
Tg(Fabp4-cre)1Abel/0

(involves: FVB)
abnormal adipose tissue development J:159612
abnormal white adipose tissue physiology J:159612
decreased body fat mass J:159612
decreased epididymal fat pad weight J:159612
decreased inguinal fat pad weight J:159612
decreased mesenteric fat pad weight J:159612
decreased renal fat pad weight J:159612
decreased subcutaneous adipose tissue amount J:159612
decreased white adipose tissue amount J:159612
decreased white fat cell size J:159612
Gnf1C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52))
decreased total body fat amount J:99312
Gnf2C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52))
decreased total body fat amount J:99312
Gnf3C57BL/6J/?
(involves: M16i * M16i.B6-(D2Mit306-D2Mit52))
decreased total body fat amount J:99312
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N)
decreased inguinal fat pad weight J:92791
decreased retroperitoneal fat pad weight J:92791
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N)
decreased inguinal fat pad weight J:92791
decreased retroperitoneal fat pad weight J:92791
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ)
decreased gonadal fat pad weight J:134068
decreased percent body fat/body weight J:134068
decreased retroperitoneal fat pad weight J:134068
Gpamtm1Lex/Gpamtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
decreased percent body fat/body weight J:185494
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J)
decreased gonadal fat pad weight J:84541
decreased percent body fat/body weight J:84541
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6)
decreased brown adipose tissue amount J:213618
decreased total body fat amount J:213618
decreased total fat pad weight J:213618
Gpbar1tm1.1(KOMP)Vlcg/Gpbar1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpbar1tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Gpbar1tm1Ktan/Gpbar1+
(involves: 129X1/SvJ * C57BL/6N)
abnormal adipose tissue amount J:114971
Gpbar1tm1Ktan/Gpbar1tm1Ktan
(involves: 129X1/SvJ * C57BL/6N)
abnormal adipose tissue amount J:114971
Gpd2tm1Lbr/Gpd2tm1Lbr
(B6.129X1-Gpd2tm1Lbr)
decreased epididymal fat pad weight J:78828
decreased parametrial fat pad weight J:78828
decreased white adipose tissue amount J:78828
Gpd2tm1Tka/Gpd2tm1Tka
(B6.Cg-Gpd2tm1Tka)
decreased brown adipose tissue mass J:87244
decreased brown fat cell lipid droplet size J:87244
Gpld1tm1.1(KOMP)Vlcg/Gpld1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpld1tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Gpm6atm1Lex/Gpm6atm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
increased percent body fat/body weight J:103485
Gpr1tm1.1Dgen/Gpr1tm1.1Dgen
(involves: C57BL/6J)
decreased brown fat cell size J:273922
decreased white fat cell size J:273922
increased white fat cell size J:273922
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen)
increased gonadal fat pad weight J:111942
increased percent body fat/body weight J:111942
increased retroperitoneal fat pad weight J:111942
Gpr15em1(IMPC)J/Gpr15em1(IMPC)J
(C57BL/6NJ-Gpr15em1(IMPC)J/J)
increased total body fat amount J:211773
Gpr21tm1Dgen/Gpr21tm1Dgen
(B6.129P2-Gpr21tm1Dgen)
decreased percent body fat/body weight J:181127
Gpr22tm1b(KOMP)Wtsi/Gpr22tm1b(KOMP)Wtsi
(C57BL/6N-Gpr22tm1b(KOMP)Wtsi/H)
decreased total body fat amount J:211773
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6)
increased total body fat amount J:189617
Gpr37tm1Dgen/Gpr37tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
increased percent body fat/body weight J:101679
Gpr39tm1Lex/Gpr39tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
increased percent body fat/body weight J:124913
Gpr50tm1Dgen/Gpr50tm1Dgen
(involves: C57BL/6)
decreased percent body fat/body weight J:131227
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(B6.Cg-Gpr68tm1.1Yaxu)
adipose tissue phenotype J:149315
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
abnormal brown adipose tissue morphology J:149315
increased brown adipose tissue amount J:149315
Gpr68tm1Yaxu/Gpr68tm1Yaxu
(involves: C57BL/6)
abnormal brown adipose tissue morphology J:149315
decreased brown adipose tissue amount J:149315
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6)
increased white adipose tissue amount J:144372
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
decreased white adipose tissue amount J:138126
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Adipoq-cre)#Pesch/0

(involves: 129S/SvEv * FVB)
abnormal adipose tissue physiology J:213603
abnormal brown adipose tissue physiology J:213603
abnormal epididymal fat pad morphology J:213603
abnormal interscapular fat pad morphology J:213603
increased body fat mass J:213603
increased brown fat cell size J:213603
increased white fat cell size J:213603
whitened brown adipose tissue morphology J:213603
Grb10tm1.1Fliu/Grb10tm1.1Fliu
Tg(Fabp4-cre)1Rev/0

(involves: 129S/SvEv)
abnormal epididymal fat pad morphology J:213603
increased body fat mass J:213603
increased brown fat cell size J:213603
increased white fat cell size J:213603
whitened brown adipose tissue morphology J:213603
Greb1tm1b(KOMP)Wtsi/Greb1tm1b(KOMP)Wtsi
(C57BL/6N-Greb1tm1b(KOMP)Wtsi/Bay)
decreased total body fat amount J:211773
Grm1crv4/Grm1crv4
(BALB/cPas-Grm1crv4)
increased brown adipose tissue amount J:112290
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
decreased total body fat amount J:82809
Grm7em1(IMPC)H/Grm7em1(IMPC)H
(C57BL/6NTac-Grm7em1(IMPC)H/H)
decreased total body fat amount J:211773
Grm8tm1Duv/Grm8tm1Duv
(B6.129S1-Grm8tm1Duv)
increased percent body fat/body weight J:101087
Gsk3atm1.1Jrw/Gsk3atm1.1Jrw
(involves: 129S6/SvEvTac * C57BL/6)
decreased percent body fat/body weight J:130033
Gsk3atm1a(EUCOMM)Wtsi/Gsk3atm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Gsk3atm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
Gstcdtm1b(EUCOMM)Wtsi/Gstcdtm1b(EUCOMM)Wtsi
(C57BL/6N-Gstcdtm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Gsto1em1(IMPC)J/Gsto1em1(IMPC)J
(C57BL/6NJ-Gsto1em1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Gt(ROSA)26Sortm1(Akt1/EGFP)Glas/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased total body fat amount J:94134
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Tardbptm1.1Pcw/Tardbp+

(involves: 129 * C57BL/6 * SJL)
decreased total body fat amount J:164406
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Tardbptm1.1Pcw/Tardbptm1.1Pcw

(involves: 129 * C57BL/6 * SJL)
decreased total body fat amount J:164406
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
Tg(Pomc-EGFP)1Low/0
Tg(Gnrh1-cre)1Dlc/0

(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
increased abdominal adipose tissue amount J:199640
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg
Tg(BGLAP-cre/ERT2)#Stko/0

(involves: 129S1/Sv * FVB/N)
decreased gonadal fat pad weight J:201507
decreased white fat cell number J:201507
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/?
Oxttm1.1(cre)Dolsn/Oxt+

(involves: 129S6/SvEvTac * C57BL/6)
increased total body fat amount J:192007
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0

(involves: C57BL/6 * FVB/N)
increased retroperitoneal fat pad weight J:169459
increased subcutaneous adipose tissue amount J:169459
increased total body fat amount J:169459
Gt(ROSA)26Sortm1(Irx3*)Hui/Gt(ROSA)26Sor+
Tg(Ins2-cre)25Mgn/0

(involves: C57BL/6 * DBA)
abnormal white adipose tissue physiology J:208887
decreased fat cell size J:208887
decreased percent body fat/body weight J:208887
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Lepob/Lepob
Tg(Adipoq-cre)1Evdr/0

(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)
adipose tissue phenotype J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Ptentm1Hwu/Ptentm1Hwu
Tg(Adipoq-cre)1Evdr/0

(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/NJ)
abnormal brown adipose tissue morphology J:237232
lipodystrophy J:237232
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Tg(Adipoq-cre)1Evdr/0

(involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)
abnormal white fat cell differentation J:237232
absent epididymal fat pad J:237232
lipodystrophy J:237232
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
Tg(tetO-Xbp1_is)#Pesch/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)
decreased total body fat amount J:194290
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Agrp-cre)1Gsb/0

(involves: 129 * C57BL/6J * FVB/N)
adipose tissue phenotype J:209418
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Pomc1-cre)16Lowl/0

(involves: 129 * C57BL/6J * FVB/N)
decreased epididymal fat pad weight J:209418
decreased total body fat amount J:209418
Gt(ROSA)26Sortm1(Tgfbr1*)Crm/Gt(ROSA)26Sor+
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0

(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
decreased subcutaneous adipose tissue amount J:134135
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
increased abdominal fat pad weight J:166829
increased total body fat amount J:166829
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
increased abdominal fat pad weight J:166829
increased total body fat amount J:166829
Gt(ROSA)26Sortm2(Foxo1)Jnk/Gt(ROSA)26Sor+
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0

(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
increased total body fat amount J:162892
Gt(ROSA)26Sortm2(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Agrp-cre)1Gsb/0

(involves: 129 * C57BL/6J * FVB/N)
adipose tissue phenotype J:209418
Gt(ROSA)26Sortm2(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Pomc1-cre)16Lowl/0

(involves: 129 * C57BL/6J * FVB/N)
adipose tissue phenotype J:209418
Gt(ROSA)26Sortm2(STAT3,EGFP)Cgn/?
Tg(Fabp4-cre/ERT2)1Ipc/0
Tyk2tm1Shmd/Tyk2tm1Shmd

(involves: 129P2/OlaHsd * C57BL/6 * SJL)
adipose tissue phenotype J:195099
Gt(ROSA)26Sortm2(STAT3,EGFP)Cgn/Gt(ROSA)26Sortm2(STAT3,EGFP)Cgn
Tg(Agrp-cre)1Gsb/?

(involves: C57BL/6 * FVB/N)
decreased gonadal fat pad weight J:133218
Gt(ROSA)26Sortm3(Irf4)Evdr/Gt(ROSA)26Sor+
Tg(Ucp1-cre)1Evdr/0

(involves: 129 * C57BL/6J * FVB)
abnormal adipose tissue development J:214637
abnormal white fat cell size J:214637
browned white adipose tissue morphology J:214637
decreased body fat mass J:214637
decreased epididymal fat pad weight J:214637
decreased inguinal fat pad weight J:214637
Gt(ROSA)26Sortm3(RNAi:Fabp4)Mrl/Gt(ROSA)26Sor+
(B6NTac.Cg-Gt(ROSA)26Sortm3(RNAi:Fabp4)Mrl)
increased total body fat amount J:177476
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
decreased total body fat amount J:182346
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar)
increased subcutaneous adipose tissue amount J:178241
increased total body fat amount J:178241
Gusbmps/Gusbmps
(involves: C57BL/6By)
decreased white adipose tissue amount J:13923
Gy/Y
(involves: C3H/Sn * C57BL/6Ei)
decreased total body fat amount J:88352
H1f10tm1.1(KOMP)Vlcg/H1f10tm1.1(KOMP)Vlcg
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
H2al2aem1(IMPC)Wtsi/H2al2aem1(IMPC)Wtsi
(C57BL/6N-H2al2aem1(IMPC)Wtsi/Wtsi)
increased total body fat amount J:211773
H13tm1b(KOMP)Wtsi/H13+
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg)
decreased total body fat amount J:179084
Hadhbm1Yuan/Hadhbm1Yuan
(C57BL/6J-Hadhbm1Yuan)
abnormal brown adipose tissue morphology J:117738
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Hdac3tm1Swh/Hdac3tm1.1Swh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S6/SvEvTac * C57BL/6 * DBA)
decreased total body fat amount J:134288
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
increased brown adipose tissue amount J:85774
increased epididymal fat pad weight J:85774
increased interscapular fat pad weight J:85774
increased white adipose tissue amount J:85774
increased white fat cell size J:85774
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J)
decreased subcutaneous adipose tissue amount J:107145
Herc1em3(IMPC)Wtsi/Herc1em3(IMPC)Wtsi
(C57BL/6N-Herc1em3(IMPC)Wtsi/Wtsi)
increased total body fat amount J:211773
Herc2mpc178H/Herc2mpc178H
(involves: BALB/c * C3H/HeH * C57BL/6J)
decreased body fat mass J:234901
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
decreased total body fat amount J:87617
Hgsnatem4(IMPC)Tcp/Hgsnatem4(IMPC)Tcp
(C57BL/6NCrl-Hgsnatem4(IMPC)Tcp/Tcp)
decreased total body fat amount J:211773
Hhatlem1(IMPC)Mbp/Hhatlem1(IMPC)Mbp
(C57BL/6N-Hhatlem1(IMPC)Mbp/Ucd)
decreased total body fat amount J:211773
Hibadhtm1b(EUCOMM)Wtsi/Hibadhtm1b(EUCOMM)Wtsi
(C57BL/6N-Hibadhtm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo)
decreased epididymal fat pad weight J:160941
decreased white fat cell size J:160941
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
abnormal retroperitoneal fat pad morphology J:237329
Hip1rtm2b(KOMP)Wtsi/Hip1rtm2b(KOMP)Wtsi
(C57BL/6N-Hip1rtm2b(KOMP)Wtsi/Bay)
decreased total body fat amount J:211773
Hlb44/?
(C57BL/6J-Hlb44)
increased percent body fat/body weight J:82961
hlb52/?
(C57BL/6J-hlb52/J)
increased percent body fat/body weight J:82961
hlb52/hlb52
(C57BL/6J-hlb52/J)
increased percent body fat/body weight J:82961
Hlb80/?
(C57BL/6J-Hlb80)
increased percent body fat/body weight J:82961
Hlb81/?
(C57BL/6J-Hlb81)
increased percent body fat/body weight J:82961
Hlb93/?
(C57BL/6J-Hlb93)
increased percent body fat/body weight J:82961
hlb124/?
(C57BL/6J-hlb124/J)
increased percent body fat/body weight J:82961
Hlb125/?
(C57BL/6J-Hlb125)
increased percent body fat/body weight J:82961
Hlb131/?
(C57BL/6J-Hlb131/J)
increased percent body fat/body weight J:82961
Hlb132/?
(C57BL/6J-Hlb132)
increased percent body fat/body weight J:82961
Hlb147/?
(C57BL/6J-Hlb147)
increased percent body fat/body weight J:82961
Hlb163/?
(C57BL/6J-Hlb163)
increased percent body fat/body weight J:82961
Hlb181/?
(C57BL/6J-Hlb181)
increased percent body fat/body weight J:82961
Hlb197/?
(C57BL/6J-Hlb197)
increased percent body fat/body weight J:82961
Hlb199/?
(C57BL/6J-Hlb199)
increased percent body fat/body weight J:82961
Hlb228/?
(involves: 129 * C57BL/6)
increased percent body fat/body weight J:82961
Hlb230/?
(C57BL/6J-Hlb230/J)
increased percent body fat/body weight J:82961
hlb349A/hlb349A
(involves: 129S1/SvImJ * C57BL/6J)
increased percent body fat/body weight J:82961
hlb541/?
(C57BL/6J-hlb541/J)
increased percent body fat/body weight J:77944
hlb575/hlb575
(C57BL/6J-hlb575/J)
increased percent body fat/body weight J:82961
hlb579/?
(C57BL/6J-hlb579/J)
increased percent body fat/body weight J:77944
hlb583/?
(C57BL/6J-hlb583/J)
increased percent body fat/body weight J:77944
Hmga2pg-Tg40BCha/Hmga2+
(involves: C57BL/6J * CBA/J)
decreased percent body fat/body weight J:21153
Hmga2pg-Tg40BCha/Hmga2pg-Tg40BCha
(involves: C57BL/6J * CBA/J)
decreased percent body fat/body weight J:21153
Hmga2tm1Cha/Hmga2tm1Cha
Lepob/Lepob

(involves: 129S7/SvEvBrd * C57BL/6J)
abnormal fat pad morphology J:61493
decreased inguinal fat pad weight J:61493
decreased mesenteric fat pad weight J:61493
Hmox1tm1.1Hes/Hmox1tm1.1Hes
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
decreased fat cell size J:214639
Hmx2tm1.1(KOMP)Vlcg/Hmx2tm1.1(KOMP)Vlcg
(C57BL/6N-Hmx2tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
absent subcutaneous adipose tissue J:31627
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas)
absent subcutaneous adipose tissue J:31627
Hook3tm1b(NCOM)Mfgc/Hook3tm1b(NCOM)Mfgc
(C57BL/6N-Hook3tm1b(NCOM)Mfgc/Tcp)
decreased total body fat amount J:211773
Hoxa10tm1.1(KOMP)Vlcg/Hoxa10tm1.1(KOMP)Vlcg
(C57BL/6N-Hoxa10tm1.1(KOMP)Vlcg/Ucd)
decreased total body fat amount J:211773
Hrctm1Blk/Hrctm1Blk
(B6.129S6-Hrctm1Blk)
abnormal fat pad morphology J:117648
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
decreased total body fat amount J:107191
increased brown adipose tissue amount J:107191
increased fat cell size J:107191
increased white adipose tissue amount J:107191
Hrh3tm1Kot/Hrh3tm1Kot
(involves: 129X1/SvJ * C57BL/6N)
increased total body fat amount J:80824
Hsbp1l1em1(IMPC)J/Hsbp1l1em1(IMPC)J
(C57BL/6NJ-Hsbp1l1em1(IMPC)J/J)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Hsd11b1tm1.2Tuck/Hsd11b1tm1.2Tuck
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal epididymal fat pad morphology J:203302
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N)
increased subcutaneous adipose tissue amount J:214146
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1)
abnormal abdominal fat pad morphology J:89080
abnormal epididymal fat pad morphology J:89080
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(B6.129P2(Cg)-Hsd11b1tm1Yko)
abnormal abdominal fat pad morphology J:89080
abnormal epididymal fat pad morphology J:89080
Hspa5tm1.1(KOMP)Vlcg/Hspa5+
(C57BL/6N-Hspa5tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
increased total body fat amount J:211773
Hspbap1tm1b(EUCOMM)Hmgu/Hspbap1tm1b(EUCOMM)Hmgu
(C57BL/6N-Hspbap1tm1b(EUCOMM)Hmgu/Bay)
decreased total body fat amount J:211773
Htr1btm1.1(KOMP)Vlcg/Htr1b+
(C57BL/6N-Htr1btm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Htr2btm1b(EUCOMM)Wtsi/Htr2b+
(C57BL/6N-Htr2btm1b(EUCOMM)Wtsi/Nju)
increased total body fat amount J:211773
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke)
increased percent body fat/body weight J:147514
increased white adipose tissue amount J:147514
Htr2ctm1Jke/Y
Tg(Pomc1-cre)16Lowl/0

(B6.Cg-Htr2ctm1Jke Tg(Pomc1-cre)16Lowl)
adipose tissue phenotype J:147514
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2))
increased epididymal fat pad weight J:24339
increased renal fat pad weight J:24339
increased white adipose tissue amount J:24339
Htr2ctm1Jul/Y
(B6.129S-Htr2ctm1Jul)
increased epididymal fat pad weight J:50262
increased renal fat pad weight J:50262
increased white adipose tissue amount J:50262
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk)
decreased body fat mass J:142503
decreased brown adipose tissue mass J:142503
decreased white adipose tissue amount J:142503
Htr2ctm2Lex/Htr2ctm2Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
adipose tissue phenotype J:185494
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp)
decreased white adipose tissue amount J:87451
Htr6tm1Arte/Htr6tm1Arte
(involves: C57BL/6)
decreased total body fat amount J:145073
Htr7tm1b(KOMP)Wtsi/Htr7tm1b(KOMP)Wtsi
(C57BL/6N-Htr7tm1b(KOMP)Wtsi/J)
decreased total body fat amount J:211773
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei)
decreased total body fat amount J:50420
Hvf/Hvf+
(involves: C3H/HeH * C57BL/6J)
decreased body fat mass J:277886
Hyal4tm2b(EUCOMM)Wtsi/Hyal4tm2b(EUCOMM)Wtsi
(C57BL/6N-Hyal4tm2b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Ica1tm1b(EUCOMM)Wtsi/Ica1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ica1tm1b(EUCOMM)Wtsi/Tcp)
decreased total body fat amount J:211773
Id2tm1Ago/Id2tm1Ago
(B6.129-Id2tm1Ago)
adipose tissue phenotype J:138276
decreased inguinal fat pad weight J:138276
decreased interscapular fat pad weight J:138276
decreased white adipose tissue amount J:138276
Id4tm1Fsky/Id4tm1Fsky
(involves: 129P2/OlaHsd)
abnormal fat cell morphology J:162236
Idetm1a(EUCOMM)Wtsi/Idetm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Idetm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
Iduatm1.1Kmke/Iduatm1.1Kmke
(B6.129-Iduatm1.1Kmke)
decreased percent body fat/body weight J:155619
Ifnar1tm2a(EUCOMM)Wtsi/Ifnar1tm2a(EUCOMM)Wtsi
(C57BL/6N-Ifnar1tm2a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:211773
Igf1tm1.1Dlr/Igf1tm1.1Dlr
Tg(Ttr-IGF1)1Sykr/0

(FVB.Cg-Igf1tm1.1Dlr Tg(Ttr-IGF1)1Sykr)
decreased gonadal fat pad weight J:157350
decreased percent body fat/body weight J:157350
decreased total body fat amount J:157350
Igf1tm1Arge/Igf1+
Liftm1Stw/Liftm1Stw

(involves: 129S/SvEv * 129S1/Sv * C57BL/6 * MF1)
abnormal white fat cell morphology J:87585
decreased gonadal fat pad weight J:87585
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Tg(Fabp4-cre)1Abel/?

(involves: C57BL/6 * FVB/N)
abnormal fat cell morphology J:141321
abnormal gonadal fat pad morphology J:141321
increased fat cell size J:141321
increased total body fat amount J:141321
Igf1sl1C3H/HeJ/Igf1sl1C3H/HeJ
(B6.C3-(D6Mit93-D6Mit150))
decreased total body fat amount J:112375
increased percent body fat/body weight J:99471
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini)
abnormal brown adipose tissue thermogenesis J:271356
decreased subcutaneous adipose tissue amount J:271356
decreased total body fat amount J:271356
decreased white adipose tissue amount J:271356
decreased white fat cell number J:271356
whitened brown adipose tissue morphology J:271356
Igfbp3tm1Jep/Igfbp3tm1Jep
Igfbp4tm1Jep/Igfbp4tm1Jep
Igfbp5tm1Jep/Igfbp5tm1Jep

(involves: 129S/SvEv * C57BL/6J)
abnormal abdominal fat pad morphology J:112029
decreased total fat pad weight J:112029
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
decreased white adipose tissue amount J:168345
Ighmbp2em1(IMPC)Tcp/Ighmbp2+
(C57BL/6NCrl-Ighmbp2em1(IMPC)Tcp/Tcp)
increased total body fat amount J:211773
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
absent subcutaneous adipose tissue J:63054
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
increased abdominal fat pad weight J:108634
increased gonadal fat pad weight J:108634
increased inguinal fat pad weight J:108634
increased mesenteric fat pad weight J:108634
increased percent body fat/body weight J:108634
increased retroperitoneal fat pad weight J:108634
increased total body fat amount J:108634
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr
Tg(Alb1-cre)7Gsc/0

(involves: C57BL/6 * FVB/N)
adipose tissue phenotype J:166367
decreased adipocyte glucose uptake J:166367
Il12rb1tm1b(KOMP)Wtsi/Il12rb1tm1b(KOMP)Wtsi
(C57BL/6N-Il12rb1tm1b(KOMP)Wtsi/Bay)
decreased total body fat amount J:211773
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd)
increased percent body fat/body weight J:122588
increased total fat pad weight J:122588
increased white adipose tissue amount J:122588
Il33em2(IMPC)Bay/Il33em2(IMPC)Bay
(C57BL/6N-Il33em2(IMPC)Bay/Bay)
decreased total body fat amount J:211773
Ilrunem1(IMPC)Tcp/Ilrunem1(IMPC)Tcp
(C57BL/6NCrl-Ilrunem1(IMPC)Tcp/Tcp)
increased total body fat amount J:211773
inad/inad
(C57BL/6-inad)
decreased total body fat amount J:97670
Ino80dtm1b(EUCOMM)Wtsi/Ino80d+
(C57BL/6N-Ino80dtm1b(EUCOMM)Wtsi/Bay)
decreased total body fat amount J:211773
Ins2Akita/?
(involves: C57BL/6NSlc)
decreased adipocyte glucose uptake J:130021
decreased body fat mass J:130021
increased adipocyte glucose uptake J:130021
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita)
decreased subcutaneous adipose tissue amount J:108948
Insig1tm1.1Aztc/Insig1tm1.1Aztc
(Not Specified)
abnormal white fat cell differentation J:208931
abnormal white fat cell morphology J:208931
increased gonadal fat pad weight J:208931
increased subcutaneous adipose tissue amount J:208931
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L2Dac/0

(involves: 129S4/SvJae * C57BL/6 * FVB)
decreased white adipose tissue amount J:91350
Insrtm1Dac/Insrtm1Dac
Tg(TTR-INSR)L3Dac/0

(involves: 129S4/SvJae * C57BL/6 * FVB)
decreased white adipose tissue amount J:91350
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
decreased total body fat amount J:80773
Insrtm1Jja/Insrtm1Jja
Tg(PAH-INSR)1Rjv/0

(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2)
abnormal inguinal fat pad morphology J:80773
Insrtm1Khn/Insrtm1Khn
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Pomc1-cre)16Lowl/0

(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)
abnormal gonadal fat pad morphology J:192274
adipose tissue inflammation J:192274
increased abdominal adipose tissue amount J:192274
increased fat cell size J:192274
increased percent body fat/body weight J:192274
Insrtm1Khn/Insrtm1Khn
Tg(Ckmm-cre)5Khn/0

(involves: 129S4/SvJae * C57BL/6J * FVB)
abnormal fat pad morphology J:51266
Insrtm1Khn/Insrtm1Khn
Tg(Nes-cre)1Kln/0

(involves: 129S4/SvJae * C57BL/6J * SJL)
increased white adipose tissue amount J:64790
Insrtm1Khn/Insrtm1Khn
Tg(Slc2a4-cre)546Dac/0

(involves: 129S4/SvJaeSor * C57BL/6 * FVB)
abnormal brown adipose tissue morphology J:169404
abnormal epididymal fat pad morphology J:169404
increased brown fat cell lipid droplet size J:169404
Insrtm1Shs/Insr+
(involves: C57BL/6CrSlc)
decreased total body fat amount J:98723
Iqsec3tm3b(KOMP)Wtsi/Iqsec3tm3b(KOMP)Wtsi
(C57BL/6N-Iqsec3tm3b(KOMP)Wtsi/Bay)
increased total body fat amount J:211773
Irf4tm1Rdf/Irf4tm1Rdf
Tg(Ucp1-cre)1Evdr/0

(involves: 129S1/Sv * C57BL/6J * FVB)
abnormal adipose tissue development J:214637
increased body fat mass J:214637
increased epididymal fat pad weight J:214637
increased inguinal fat pad weight J:214637
increased white fat cell size J:214637
Irs1Sml/Irs1+
(C3.Cg-Irs1Sml H2b/GrsrJ)
decreased total body fat amount J:163661
Irs1Sml/Irs1Sml
(C3.Cg-Irs1Sml H2b/GrsrJ)
decreased percent body fat/body weight J:163661
Irs1tm1Jos/Irs1tm1Jos
Irs3tm1Lhd/Irs3tm1Lhd

(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
abnormal gonadal fat pad morphology J:80976
decreased white adipose tissue amount J:80976
Irs1tm1Tka/Irs1tm1Tka
Irs2tm1Tka/Irs2tm1Tka

(involves: C57BL/6 * CBA)
decreased white adipose tissue amount J:68004
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
increased total body fat amount J:64791
Irs2tm1With/Irs2tm1With
Tg(Nes-cre)1Kln/0

(involves: 129S6/SvEvTac * C57BL/6J)
increased total body fat amount J:97406
Irs2tm2Mfw/Irs2tm2Mfw
Irs4tm1.1Mfw/Y
Tg(Nes-cre)1Kln/?

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
abnormal adipose tissue amount J:221293
increased brown fat cell lipid droplet size J:221293
Irs2tm2Mfw/Irs2tm2Mfw
Tg(Ins2-cre)25Mgn/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased total body fat amount J:93415
Irs2tm2Tka/Irs2tm2Tka
Tg(Ins2-cre)25Mgn/0

(involves: 129S4/SvJae * C57BL/6)
increased epididymal fat pad weight J:93416
Irx1tm1.1(KOMP)Vlcg/Irx1+
(C57BL/6N-Irx1tm1.1(KOMP)Vlcg/J)
decreased total body fat amount J:211773
Irx3tm1Hui/Irx3tm1Hui
(involves: 129S1/Sv * 129X1/SvJ)
abnormal white adipose tissue physiology J:208887
decreased fat cell size J:208887
decreased percent body fat/body weight J:208887
Itgb3bpem1(IMPC)J/Itgb3bpem1(IMPC)J
(C57BL/6NJ-Itgb3bpem1(IMPC)J/Mmjax)
increased total body fat amount J:211773
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa)
decreased brown adipose tissue mass J:144968
decreased epididymal fat pad weight J:144968
decreased fat cell size J:144968
decreased subcutaneous adipose tissue amount J:144968
increased adipocyte glucose uptake J:144968
Izumo1rtm2a(KOMP)Wtsi/Izumo1rtm2a(KOMP)Wtsi
(C57BL/6N-Izumo1rtm2a(KOMP)Wtsi/Wtsi)
decreased total body fat amount J:211773
Jdp2tm1Kkyo/Jdp2tm1Kkyo
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal fat cell morphology J:139241
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J)
decreased total fat pad weight J:210545
Juptm1Ruiz/Jup+
(involves: 129P2/OlaHsd * C57BL/6)
abnormal fat cell differentiation J:192719
Juptm1Ruiz/Jup+
Tg(Myh6-Jup*)1Ajm/0

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
abnormal fat cell morphology J:192719
Kat6bGt(pKC199)1Pgr/Kat6bGt(pKC199)1Pgr
(involves: 129S2/SvPas)
decreased percent body fat/body weight J:178264
Kazntm1a(EUCOMM)Wtsi/Kazntm1a(EUCOMM)Wtsi
(C57BL/6N-Kazntm1a(EUCOMM)Wtsi/Wtsi)
decreased total body fat amount J:175295
Kbtbd2em1Btlr/Kbtbd2em1Btlr
Pik3r1em1Btlr/Pik3r1em1Btlr

(Not Specified)
increased body fat mass J:236520
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr)
abnormal white adipose tissue physiology J:236520
decreased epididymal fat pad weight J:236520
decreased inguinal fat pad weight J:236520
Kcnd3em1(IMPC)J/Kcnd3em1(IMPC)J
(C57BL/6NJ-Kcnd3em1(IMPC)J/J)
decreased total body fat amount J:211773
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse)
decreased abdominal fat pad weight J:157001
decreased subcutaneous adipose tissue amount J:1570